CN102105433B - 6-nitroacetophenone compound, its preparation method and use - Google Patents
6-nitroacetophenone compound, its preparation method and use Download PDFInfo
- Publication number
- CN102105433B CN102105433B CN200980129186.8A CN200980129186A CN102105433B CN 102105433 B CN102105433 B CN 102105433B CN 200980129186 A CN200980129186 A CN 200980129186A CN 102105433 B CN102105433 B CN 102105433B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- reaction
- cyano
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 150000001875 compounds Chemical class 0.000 claims abstract description 215
- -1 3-substituted-4-hydroxyquinoline compounds Chemical class 0.000 claims abstract description 94
- 239000000543 intermediate Substances 0.000 claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims description 136
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 111
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 94
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 94
- 229940126062 Compound A Drugs 0.000 claims description 46
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 26
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 claims description 16
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 claims description 16
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 15
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims description 14
- 125000003342 alkenyl group Chemical group 0.000 claims description 14
- 125000001589 carboacyl group Chemical group 0.000 claims description 13
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 claims description 13
- 238000005984 hydrogenation reaction Methods 0.000 claims description 13
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 12
- 238000007363 ring formation reaction Methods 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 11
- 238000006482 condensation reaction Methods 0.000 claims description 11
- 229960000583 acetic acid Drugs 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 9
- 239000003054 catalyst Substances 0.000 claims description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 8
- 239000012362 glacial acetic acid Substances 0.000 claims description 8
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims description 7
- 239000003638 chemical reducing agent Substances 0.000 claims description 7
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 7
- 238000006467 substitution reaction Methods 0.000 claims description 7
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- XCCVLPJKUYIJTP-UHFFFAOYSA-N n-[5-(2-cyanoacetyl)-2-ethoxy-4-nitrophenyl]acetamide Chemical compound CCOC1=CC([N+]([O-])=O)=C(C(=O)CC#N)C=C1NC(C)=O XCCVLPJKUYIJTP-UHFFFAOYSA-N 0.000 claims description 6
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- 125000006725 C1-C10 alkenyl group Chemical group 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical group C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims description 5
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims description 5
- FMCAFXHLMUOIGG-IWFBPKFRSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-formamido-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxy-2,5-dimethylphenyl)propanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound O=CN[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(O)=O)CC1=CC(C)=C(O)C=C1C FMCAFXHLMUOIGG-IWFBPKFRSA-N 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 4
- 125000006239 protecting group Chemical group 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 claims description 4
- 150000008065 acid anhydrides Chemical class 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 238000005660 chlorination reaction Methods 0.000 claims description 3
- 238000006114 decarboxylation reaction Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 claims description 2
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 238000005580 one pot reaction Methods 0.000 claims description 2
- 239000001119 stannous chloride Substances 0.000 claims description 2
- 235000011150 stannous chloride Nutrition 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 72
- 239000000243 solution Substances 0.000 description 71
- 239000007787 solid Substances 0.000 description 46
- 230000015572 biosynthetic process Effects 0.000 description 45
- 238000003786 synthesis reaction Methods 0.000 description 44
- 125000003118 aryl group Chemical group 0.000 description 40
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 28
- 239000000843 powder Substances 0.000 description 26
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 20
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 17
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- OVURAHRGGCJNEB-UHFFFAOYSA-N n-(3-cyano-7-ethoxy-4-oxo-1h-quinolin-6-yl)acetamide Chemical compound C1=C(C#N)C(O)=C2C=C(NC(C)=O)C(OCC)=CC2=N1 OVURAHRGGCJNEB-UHFFFAOYSA-N 0.000 description 16
- 238000003756 stirring Methods 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000010992 reflux Methods 0.000 description 12
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 11
- 239000005457 ice water Substances 0.000 description 11
- 238000005160 1H NMR spectroscopy Methods 0.000 description 9
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 229940073735 4-hydroxy acetophenone Drugs 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- 125000003545 alkoxy group Chemical group 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 8
- 125000000623 heterocyclic group Chemical group 0.000 description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 238000000967 suction filtration Methods 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 125000003435 aroyl group Chemical group 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 0 CC(c1cc(**)c(*)cc1)=O Chemical compound CC(c1cc(**)c(*)cc1)=O 0.000 description 5
- NWEMEWRUJFXFPN-UHFFFAOYSA-N N-[5-(2-bromoacetyl)-2-ethoxy-4-nitrophenyl]acetamide Chemical compound C(C)(=O)NC=1C(=CC(=C(C=1)C(CBr)=O)[N+](=O)[O-])OCC NWEMEWRUJFXFPN-UHFFFAOYSA-N 0.000 description 5
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 4
- BIQRONJDHFVIQJ-UHFFFAOYSA-N 5-acetamido-4-ethoxy-2-nitrobenzoyl chloride Chemical compound C(C)(=O)NC=1C(=CC(=C(C(=O)Cl)C=1)[N+](=O)[O-])OCC BIQRONJDHFVIQJ-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 230000031709 bromination Effects 0.000 description 4
- 238000005893 bromination reaction Methods 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 238000006396 nitration reaction Methods 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- MMNKVWGVSHRIJL-UHFFFAOYSA-N 4'-hydroxy-3'-nitroacetophenone Chemical compound CC(=O)C1=CC=C(O)C([N+]([O-])=O)=C1 MMNKVWGVSHRIJL-UHFFFAOYSA-N 0.000 description 3
- GREIDFBKECIBTM-UHFFFAOYSA-N 5-acetamido-4-ethoxy-2-nitrobenzoic acid Chemical compound CCOC1=CC([N+]([O-])=O)=C(C(O)=O)C=C1NC(C)=O GREIDFBKECIBTM-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000004185 ester group Chemical group 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 125000002757 morpholinyl group Chemical group 0.000 description 3
- 125000004193 piperazinyl group Chemical group 0.000 description 3
- 125000003386 piperidinyl group Chemical group 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical compound C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 description 2
- RYRJCZGXOAVGLF-UHFFFAOYSA-N 6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]-4-oxo-1H-quinoline-3-carbonitrile Chemical compound OC1=C(C=NC2=CC(=C(C=C12)OC)OCCCN1CCN(CC1)C)C#N RYRJCZGXOAVGLF-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- DFYRUELUNQRZTB-UHFFFAOYSA-N apocynin Chemical compound COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000012320 chlorinating reagent Substances 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- SUDAUWMVRKOWIM-UHFFFAOYSA-N methyl 3-acetamido-4-ethoxybenzoate Chemical compound CCOC1=CC=C(C(=O)OC)C=C1NC(C)=O SUDAUWMVRKOWIM-UHFFFAOYSA-N 0.000 description 2
- DGDFZZOBSYEQCJ-UHFFFAOYSA-N methyl 3-acetamido-4-hydroxybenzoate Chemical compound COC(=O)C1=CC=C(O)C(NC(C)=O)=C1 DGDFZZOBSYEQCJ-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- XDXGFTCQRAQEEG-UHFFFAOYSA-N n-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide Chemical compound C1=C(C#N)C(Cl)=C2C=C(NC(C)=O)C(OCC)=CC2=N1 XDXGFTCQRAQEEG-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- MHCVCKDNQYMGEX-UHFFFAOYSA-N 1,1'-biphenyl;phenoxybenzene Chemical compound C1=CC=CC=C1C1=CC=CC=C1.C=1C=CC=CC=1OC1=CC=CC=C1 MHCVCKDNQYMGEX-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- DLILOBLDMMRASC-UHFFFAOYSA-N 4-chloro-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile Chemical compound COC1=CC2=C(Cl)C(C#N)=CN=C2C=C1OCCCN1CCN(C)CC1 DLILOBLDMMRASC-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000003495 Coccidiosis Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 206010023076 Isosporiasis Diseases 0.000 description 1
- RLAHWVDQYNDAGG-UHFFFAOYSA-N Methanetriol Chemical compound OC(O)O RLAHWVDQYNDAGG-UHFFFAOYSA-N 0.000 description 1
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 1
- VNQABZCSYCTZMS-UHFFFAOYSA-N Orthoform Chemical compound COC(=O)C1=CC=C(O)C(N)=C1 VNQABZCSYCTZMS-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 238000006480 benzoylation reaction Methods 0.000 description 1
- UBPYILGKFZZVDX-UHFFFAOYSA-N bosutinib Chemical compound C1=C(Cl)C(OC)=CC(NC=2C3=CC(OC)=C(OCCCN4CCN(C)CC4)C=C3N=CC=2C#N)=C1Cl UBPYILGKFZZVDX-UHFFFAOYSA-N 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007333 cyanation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- 230000006203 ethylation Effects 0.000 description 1
- 238000006200 ethylation reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 150000002576 ketones Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- AOXPHVNMBPFOFS-UHFFFAOYSA-N methyl 2-nitrobenzoate Chemical compound COC(=O)C1=CC=CC=C1[N+]([O-])=O AOXPHVNMBPFOFS-UHFFFAOYSA-N 0.000 description 1
- SUNFXTJKUZVRCZ-UHFFFAOYSA-N methyl 5-acetamido-4-ethoxy-2-nitrobenzoate Chemical compound CCOC1=CC([N+]([O-])=O)=C(C(=O)OC)C=C1NC(C)=O SUNFXTJKUZVRCZ-UHFFFAOYSA-N 0.000 description 1
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical class COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Natural products O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 1
- JWNPDZNEKVCWMY-VQHVLOKHSA-N neratinib Chemical compound C=12C=C(NC(=O)\C=C\CN(C)C)C(OCC)=CC2=NC=C(C#N)C=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 JWNPDZNEKVCWMY-VQHVLOKHSA-N 0.000 description 1
- 229950008835 neratinib Drugs 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- PMZDQRJGMBOQBF-UHFFFAOYSA-N quinolin-4-ol Chemical compound C1=CC=C2C(O)=CC=NC2=C1 PMZDQRJGMBOQBF-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/45—Monoamines
- C07C211/46—Aniline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/49—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
- C07C211/50—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton with at least two amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/51—Phenylenediamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/74—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C215/76—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton of the same non-condensed six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及式I所示的6-硝基苯乙酮类化合物及其制备方法,其中取代基如说明书中所定义,及其用于制备3-取代-4-羟基喹啉类化合物和3-取代-4-氯代喹啉类化合物的用途,及式I化合物的中间体。 The present invention relates to 6-nitroacetophenone compounds shown in formula I and preparation method thereof, wherein the substituents are as defined in the description, and used for the preparation of 3-substituted-4-hydroxyquinoline compounds and 3- Uses of substituted-4-chloroquinoline compounds, and intermediates of compounds of formula I.
Description
技术领域 technical field
本发明涉及可用于制备3-取代-4-羟基喹啉类化合物和3-取代-4-氯代喹啉类化合物的6-硝基苯乙酮类化合物及其制备方法和用途,以及其中间体。更具体而言,涉及结构式如下文式I所示的6-硝基苯乙酮类化合物及其制备方法和其用于制备3-取代-4-羟基喹啉类化合物(式A所示化合物)和3-取代-4-氯代喹啉类化合物(式A’所示化合物)的用途。The present invention relates to the 6-nitroacetophenone compound that can be used for preparing 3-substituted-4-hydroxyquinoline compound and 3-substituted-4-chloroquinoline compound and its preparation method and application, and its intermediate body. More specifically, it relates to a 6-nitroacetophenone compound whose structural formula is shown in the following formula I and its preparation method and its use in the preparation of 3-substituted-4-hydroxyquinoline compounds (compounds shown in formula A) and 3-substituted-4-chloroquinoline compounds (compounds shown in formula A').
背景技术 Background technique
3-取代-4-羟基喹啉类化合物(式A)以及3-取代-4-氯代喹啉类化合物(式A’)是重要的医药中间体,是制备3,4-二取代喹啉类化合物的重要中间体。例如,3,4-二取代喹啉类化合物是不可逆小分子酪氨酸激酶抑制剂(Journal of Medicinal Chemistry,46(1):49-63),具有抗癌活性,其中的部分化合物如EKB-569和HKI-272(Journal of Medicinal Chemistry,48(4):1107-1131)等对治疗大肠癌、乳腺癌和非小细胞肺癌有效,已经进入临床研究阶段,很有可能会成为具有较好市场前景的抗肿瘤新药。还有Bosutinib(SKI-606)(Journal of Medicinal Chemistry,2001,44(23),3965-3977),也是临床上很有希望的抗肿瘤新药。3-substituted-4-hydroxyquinoline compounds (formula A) and 3-substituted-4-chloroquinoline compounds (formula A') are important pharmaceutical intermediates and are used to prepare 3,4-disubstituted quinolines important intermediates of compounds. For example, 3,4-disubstituted quinoline compounds are irreversible small molecule tyrosine kinase inhibitors (Journal of Medicinal Chemistry, 46(1):49-63), which have anticancer activity, and some compounds such as EKB- 569 and HKI-272 (Journal of Medicinal Chemistry, 48(4): 1107-1131) are effective in the treatment of colorectal cancer, breast cancer and non-small cell lung cancer. Promising new antitumor drugs. There is also Bosutinib (SKI-606) (Journal of Medicinal Chemistry, 2001, 44(23), 3965-3977), which is also a clinically promising new anti-tumor drug.
当式A中的X为酯基时,不同的3,4-二取代喹啉类化合物在抗疟、抗球虫病(US3542781)或治疗II型糖尿病(WO2005073229)方面也具有广泛应用。因此,优化3-取代-4-羟基喹啉类化合物和3-取代-4-氯代喹啉类化合物的合成工艺,就具有重要的实用价值。When X in formula A is an ester group, different 3,4-disubstituted quinoline compounds are also widely used in antimalarial, anti-coccidiosis (US3542781) or treatment of type II diabetes (WO2005073229). Therefore, optimizing the synthesis process of 3-substituted-4-hydroxyquinoline compounds and 3-substituted-4-chloroquinoline compounds has important practical value.
该类化合物的关键合成步骤在于喹啉母环的形成,而喹啉母环的合成多需用到高温条件。例如当X为氰基时,式A化合物的制备方法为,将式C化合物于高沸点溶剂中加热到240℃-260℃反应10-20小时(反应式I)(WO03093241,WO2005065181,CN101012225)。所用反应条件较为苛刻,且收率低,仅为40~50%,而且高沸点溶剂如道生油(Dowtherm)在高温下不可避免的挥发对工作环境与操作人员的健康有不利影响,对环境有污染,不适合用于大规模工业生产。因此,寻找条件温和、收率高、成本低、对环境污染小的、适于工业化生产的制备方法就变得尤为迫切。The key synthetic step of this kind of compound lies in the formation of quinoline mother ring, and the synthesis of quinoline mother ring usually requires high temperature conditions. For example, when X is a cyano group, the preparation method of the compound of formula A is to heat the compound of formula C in a high boiling point solvent to 240°C-260°C for 10-20 hours (reaction formula I) (WO03093241, WO2005065181, CN101012225). The reaction conditions used are relatively harsh, and the yield is low, only 40 to 50%, and the unavoidable volatilization of high boiling point solvents such as Dowtherm at high temperature has adverse effects on the working environment and the health of operators, and has a negative impact on the environment. Pollution, not suitable for large-scale industrial production. Therefore, it is particularly urgent to find a preparation method with mild conditions, high yield, low cost, little environmental pollution and suitable for industrial production.
反应式IReaction I
发明内容 Contents of the invention
本发明人致力于寻找条件温和、操作简便、收率高、成本低、安全环保、适合大规模商业化生产的3-取代-4-羟基喹啉类化合物和3-取代-4-氯代喹啉类化合物的制备方法。由此发明了结构式如下文式I所示的6-硝基苯乙酮类化合物,并采用式I所示的6-硝基苯乙酮类化合物简便、高收率地合成了3-取代-4-羟基喹啉类化合物和3-取代-4-氯代喹啉类化合物。The inventors are committed to finding 3-substituted-4-hydroxyquinoline compounds and 3-substituted-4-chloroquine with mild conditions, easy operation, high yield, low cost, safety and environmental protection, suitable for large-scale commercial production The preparation method of morphine compound. The 6-nitroacetophenone compound shown in the following formula I has thus been invented, and the 6-nitroacetophenone compound shown in formula I is used to synthesize 3-substituted- 4-hydroxyquinoline compounds and 3-substituted-4-chloroquinoline compounds.
本发明的一个目的是提供6-硝基苯乙酮类化合物。One object of the present invention is to provide 6-nitroacetophenones.
本发明的另一个目的是提供上述6-硝基苯乙酮类化合物的制备方法。Another object of the present invention is to provide a preparation method of the above-mentioned 6-nitroacetophenone compounds.
本发明的还一目的是提供上述6-硝基苯乙酮类化合物的用途。Another object of the present invention is to provide the use of the above-mentioned 6-nitroacetophenone compounds.
本发明的又一目的是提供上述制备方法涉及的中间体。Another object of the present invention is to provide intermediates involved in the above preparation method.
本发明提供如下式I所示的6-硝基苯乙酮类化合物:The present invention provides 6-nitroacetophenone compounds shown in the following formula I:
式I中,In formula I,
X为氰基、三氟甲基、硝基、-NHCOR3、-NHCOOR3、-CONR3R3’、-N=CHR3或-CO2R3,其中R3和R3’彼此相同或不同地为氢、C1~C10烷基、C1~C10链烯基、芳基或芳基取代的C1~C10烷基;X is cyano, trifluoromethyl, nitro, -NHCOR 3 , -NHCOOR 3 , -CONR 3 R 3 ', -N=CHR 3 or -CO 2 R 3 , wherein R 3 and R 3 'are identical to each other or Variously hydrogen, C1~C10 alkyl, C1~C10 alkenyl, aryl or C1~C10 alkyl substituted by aryl;
Z为-NH-、-O-或 Z is -NH-, -O- or
R1及R1’彼此相同或不同地为甲酰基、C1~C10烷基、C1~C10链烯基、芳基、芳基取代的C1~C10烷基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基;R 1 and R 1 ' are the same or different from each other as formyl, C1-C10 alkyl, C1-C10 alkenyl, aryl, aryl-substituted C1-C10 alkyl, C1-C10 alkanoyl, aroyl, Aryl substituted C1~C10 alkanoyl, C1~C10 alkoxycarbonyl or aryl substituted C1~C10 alkoxycarbonyl;
R2为C1~C10烷基、C1~C10链烯基或芳基,所述烷基不必须地被卤素、烷氧基、芳基或者含1~2个O或N的杂环基(例如吡咯烷基、哌啶基、吗啉基、哌嗪基、高哌嗪基)取代,其中所述杂环基不必须地被C1~C10烷基或C1~C10烷氧基取代;R 2 is C1~C10 alkyl, C1~C10 alkenyl or aryl, and said alkyl is not necessarily replaced by halogen, alkoxy, aryl or heterocyclic group containing 1~2 O or N (such as Pyrrolidinyl, piperidinyl, morpholinyl, piperazinyl, homopiperazinyl), wherein the heterocyclic group is not necessarily substituted by C1~C10 alkyl or C1~C10 alkoxy;
且当Z为-O-、R1为甲基时,R2不为甲基。And when Z is -O-, R 1 is methyl, R 2 is not methyl.
在本发明优选的实施方案中,式I中,In a preferred embodiment of the present invention, in formula I,
X为氰基、三氟甲基、-NHCOR3、-NHCOOR3、-N=CHR3、C1~C10烷氧羰基或羧基;X is cyano, trifluoromethyl, -NHCOR 3 , -NHCOOR 3 , -N=CHR 3 , C1~C10 alkoxycarbonyl or carboxyl;
Z为-NH-或-O-;Z is -NH- or -O-;
R1为C1~C5烷基、乙酰基、丙酰基、苯甲酰基、叔丁氧羰基、苄基、苄氧羰基或三苯甲基;R 1 is C1~C5 alkyl, acetyl, propionyl, benzoyl, tert-butoxycarbonyl, benzyl, benzyloxycarbonyl or trityl;
R2为甲基、乙基、丙基、苄基、-(CH2)n-Cl、-(CH2)n-Br、或其中n=1~5的整数,Alkyl为C1~C5烷基。R 2 is methyl, ethyl, propyl, benzyl, -(CH 2 ) n -Cl, -(CH 2 ) n -Br, or Wherein n=1-5 integer, Alkyl is C1-C5 alkyl.
在本发明进一步优选的实施方案中,式I中,In a further preferred embodiment of the present invention, in formula I,
X为氰基(-CN)、乙氧羰基(-COOC2H5)、甲氧羰基(-COOCH3);X is cyano (-CN), ethoxycarbonyl (-COOC 2 H 5 ), methoxycarbonyl (-COOCH 3 );
Z为-NH-或-O-;Z is -NH- or -O-;
R1为乙酰基、苯甲酰基、苄基或甲基; R is acetyl, benzoyl, benzyl or methyl;
R2为乙基、-(CH2)3-Cl、-(CH2)3-Br、或 R 2 is ethyl, -(CH 2 ) 3 -Cl, -(CH 2 ) 3 -Br, or
在本发明更进一步优选的实施方案中,式I为:In a further preferred embodiment of the present invention, formula I is:
3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮;3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone;
3’-苯甲酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮;3'-benzamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone;
3’-苄胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮;3'-Benzylamino-4'-ethoxy-6'-nitro-2-cyanoacetophenone;
3’-乙酰胺基-4’-乙氧基-6’-硝基-2-乙氧基羰基苯乙酮;3'-acetamido-4'-ethoxy-6'-nitro-2-ethoxycarbonylacetophenone;
3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-硝基-2-氰基苯乙酮。3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-nitro-2-cyanoacetophenone.
本发明涉及式I所示的6-硝基苯乙酮类化合物的制备方法,其特征在于,该方法包括:The present invention relates to the preparation method of the 6-nitroacetophenone compound shown in formula I, it is characterized in that, this method comprises:
(1)当X为氰基、三氟甲基、硝基、-NHCOR3、-NHCOOR3、-CONR3R3’、-N=CHR3或-CO2R3,其中R3和R3’彼此相同或不同地为氢、C1~C10烷基、C1~C10链烯基、芳基或芳基取代的C1~C10烷基时,由化合物V经脱羧反应得到化合物I;其反应式为:(1) When X is cyano, trifluoromethyl, nitro, -NHCOR 3 , -NHCOOR 3 , -CONR 3 R 3 ', -N=CHR 3 or -CO 2 R 3 , wherein R 3 and R 3 When 'the same or different are hydrogen, C1~C10 alkyl, C1~C10 alkenyl, aryl or C1~C10 alkyl substituted by aryl, compound I is obtained from compound V through decarboxylation; its reaction formula is :
其中,in,
Z为-NH-、-O-或 Z is -NH-, -O- or
R1及R1’彼此相同或不同地为甲酰基、C1~C10烷基、C1~C10链烯基、芳基、芳基取代的C1~C10烷基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基;R 1 and R 1 ' are the same or different from each other as formyl, C1-C10 alkyl, C1-C10 alkenyl, aryl, aryl-substituted C1-C10 alkyl, C1-C10 alkanoyl, aroyl, Aryl substituted C1~C10 alkanoyl, C1~C10 alkoxycarbonyl or aryl substituted C1~C10 alkoxycarbonyl;
R2为C1~C10烷基、C1~C10链烯基或芳基,所述烷基不必须地被卤素、烷氧基、芳基或者含1~2个O或N杂环基(例如吡咯烷基、哌啶基、吗啉基、哌嗪基、高哌嗪基)取代,其中所述杂环基不必须地被C1~C10烷基或C1~C10烷氧基取代;R 2 is C1~C10 alkyl, C1~C10 alkenyl or aryl, and said alkyl is not necessarily replaced by halogen, alkoxy, aryl or heterocyclic group containing 1~2 O or N (such as pyrrole Alkyl, piperidinyl, morpholinyl, piperazinyl, homopiperazinyl), wherein the heterocyclic group is not necessarily substituted by C1~C10 alkyl or C1~C10 alkoxy;
R4为氢、C1~C10烷基、C1~C10链烯基、芳基或芳基取代的C1~C10烷基; R4 is hydrogen, C1~C10 alkyl, C1~C10 alkenyl, aryl or C1~C10 alkyl substituted by aryl;
且当Z为-O-、R1为甲基时,R2不为甲基。And when Z is -O-, R 1 is methyl, R 2 is not methyl.
其中,化合物V可由市场购买;或以3,4-二取代-6-硝基苯甲酸为原料参照实施例十五或实施例二十三的方法制备得到。3,4-二取代-6-硝基苯甲酸可由市场购买或由3,4-二取代苯甲酸甲酯经硝化、水解酯基后制备得到,也可用3-氨基-4-取代-6-硝基苯甲酸经氨基化得到,或以3-取代-4-羟基-6-硝基-苯甲酸甲酯经醚化得到。Among them, compound V can be purchased from the market; or it can be prepared by referring to the method of Example 15 or Example 23 by using 3,4-disubstituted-6-nitrobenzoic acid as a raw material. 3,4-disubstituted-6-nitrobenzoic acid can be purchased from the market or prepared from 3,4-disubstituted methyl benzoate through nitration and hydrolysis of the ester group, and 3-amino-4-substituted-6- Nitrobenzoic acid can be obtained by amination or by etherification of 3-substituted-4-hydroxy-6-nitro-benzoic acid methyl ester.
或者or
(2)当X=氰基时,由化合物B硝化得到化合物D,化合物D溴代得到化合物II,化合物II经氰基取代反应得到化合物I;其反应式为:(2) When X=cyano group, compound D is obtained by nitration of compound B, compound D is brominated to obtain compound II, and compound II obtains compound I through cyano substitution reaction; its reaction formula is:
其中Z、R1和R2的定义同上;Wherein Z, R 1 and R 2 are as defined above;
或者or
(3)当X=氰基时,由化合物B溴化得到化合物III,化合物III硝化得到化合物II,化合物II经氰基取代反应得到化合物I;其反应式为:(3) When X=cyano group, compound III is obtained by bromination of compound B, compound III is nitrated to obtain compound II, and compound II obtains compound I through cyano substitution reaction; its reaction formula is:
其中Z、R1和R2的定义同上;Wherein Z, R 1 and R 2 are as defined above;
或者or
(4)当X=氰基时,由化合物B溴代得到化合物III,化合物III经氰基取代反应得到化合物IV,化合物IV硝化得到化合物I;其反应式为:(4) When X = cyano group, compound III is obtained by bromination of compound B, compound III is subjected to cyano substitution reaction to obtain compound IV, and compound IV is nitrated to obtain compound I; its reaction formula is:
其中Z、R1和R2的定义同上;Wherein Z, R 1 and R 2 are as defined above;
在上述反应中,式I化合物的制备中,所述脱羧、溴代、硝化、氰基取代等反应都是本技术领域内的常规反应。化合物B可由市场购买,或以对羟基苯乙酮为原料参照实施例一的方法合成,或者以3-甲氧基-4-羟基苯乙酮为原料参照实施例三十五的方法合成。In the above reactions, in the preparation of the compound of formula I, the decarboxylation, bromination, nitration, cyano substitution and other reactions are all conventional reactions in the technical field. Compound B can be purchased from the market, or synthesized by referring to the method of Example 1 using p-hydroxyacetophenone as a raw material, or using 3-methoxy-4-hydroxyacetophenone as a raw material by referring to the method of Example 35.
本发明还涉及式I所示的6-硝基苯乙酮类化合物的用途,其特征在于,The present invention also relates to the purposes of 6-nitroacetophenone compound shown in formula I, it is characterized in that,
式I所示的6-硝基苯乙酮类化合物可按如下方法制备式A所示化合物,The 6-nitroacetophenone compound shown in formula I can prepare the compound shown in formula A as follows,
其中,in,
X为氰基、三氟甲基、硝基、-NHCOR3、-NHCOOR3、-CONR3R3’、-N=CHR3、或CO2R3,其中R3和R3’彼此相同或不同地为氢、C1~C10烷基、C1~C10链烯基、芳基或芳基取代的C1~C10烷基;X is cyano, trifluoromethyl, nitro, -NHCOR 3 , -NHCOOR 3 , -CONR 3 R 3 ', -N=CHR 3 , or CO 2 R 3 , wherein R 3 and R 3 'are identical to each other or Variously hydrogen, C1~C10 alkyl, C1~C10 alkenyl, aryl or C1~C10 alkyl substituted by aryl;
Z为-NH-、-O-或 Z is -NH-, -O- or
R1及R1’彼此相同或不同地为甲酰基、C1~C10烷基、C1~C10链烯基、芳基、芳基取代的C1~C10烷基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基;R 1 and R 1 ' are the same or different from each other as formyl, C1-C10 alkyl, C1-C10 alkenyl, aryl, aryl-substituted C1-C10 alkyl, C1-C10 alkanoyl, aroyl, Aryl substituted C1~C10 alkanoyl, C1~C10 alkoxycarbonyl or aryl substituted C1~C10 alkoxycarbonyl;
R2为C1~C10烷基、C1~C10链烯基或芳基,所述烷基不必须地被卤素、烷氧基、芳基或者含1~2个O或N的杂环基取代,例如吡咯烷、哌啶、吗啉、哌嗪、高哌嗪,其中所述杂环可不必须地被C1~C10烷基或C1~C10烷氧基取代;R 2 is C1~C10 alkyl, C1~C10 alkenyl or aryl, and said alkyl is not necessarily substituted by halogen, alkoxy, aryl or heterocyclic group containing 1 to 2 O or N, For example, pyrrolidine, piperidine, morpholine, piperazine, homopiperazine, wherein the heterocycle may be optionally substituted by C1~C10 alkyl or C1~C10 alkoxy;
(1)化合物I与化合物E进行缩合反应得到式VI所示化合物,(1) compound I and compound E carry out condensation reaction to obtain the compound shown in formula VI,
其中,Y为-N(R5)2或-OR5,R5、R6和R7相同或不同地选自C1~C10烷基、C1~C10链烯基、芳基和芳基取代的C1~C10烷基中。Wherein, Y is -N(R 5 ) 2 or -OR 5 , R 5 , R 6 and R 7 are the same or different selected from C1~C10 alkyl, C1~C10 alkenyl, aryl and aryl substituted Among C1~C10 alkyl groups.
化合物VI在还原条件下得到式VII所示化合物,式VII所示化合物环合得到式A所示化合物;或者化合物VII可以不经分离直接进行环合反应得到式A所示化合物;其反应式为:Compound VI obtains the compound shown in formula VII under reducing conditions, and the compound shown in formula A is obtained by cyclization of the compound shown in formula VII; or compound VII can directly carry out cyclization reaction without separation to obtain the compound shown in formula A; its reaction formula is :
或者 or
(2)化合物I在还原条件下得到化合物VIII或化合物VIII的酸加成盐,化合物VIII(或其酸加成盐)与化合物E进行缩合反应得到化合物VII和/或化合物IX,化合物VII和/或化合物IX环合得到式A所示化合物;或者化合物VII和化合物IX可以不经分离直接进行环合反应得到式A所示化合物;其反应式为:(2) Compound I obtains compound VIII or an acid addition salt of compound VIII under reducing conditions, and compound VIII (or its acid addition salt) is condensed with compound E to obtain compound VII and/or compound IX, compound VII and/or Or compound IX cyclization obtains the compound shown in formula A; Or compound VII and compound IX can directly carry out cyclization reaction to obtain the compound shown in formula A without separation; Its reaction formula is:
或or
;或者;or
(3)化合物I在还原条件下得到化合物VIII,化合物VIII的芳氨基与酸酐((R8)2O)或卤代物(例如R8Cl、R8Br)反应,得到化合物X,化合物X与化合物E进行缩合反应得到化合物XI,化合物XI经环合得到化合物XII,化合物XII脱R8保护基得到化合物A;其反应式为:(3) Compound I obtains Compound VIII under reducing conditions. The arylamino group of Compound VIII reacts with an acid anhydride ((R 8 ) 2 O) or a halide (such as R 8 Cl, R 8 Br) to obtain Compound X. Compound X and Compound E carries out condensation reaction and obtains compound XI, and compound XI obtains compound XII through cyclization, and compound XII removes R 8 protecting group obtains compound A; Its reaction formula is:
其中R8可以为一般的氨基保护基,即甲酰基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基。由化合物X制备化合物A的反应可以用一锅法完成,中间体XI和XII可以不经分离。Where R8 can be a general amino protecting group, namely formyl, C1~C10 alkanoyl, aroyl, aryl substituted C1~C10 alkanoyl, C1~C10 alkoxycarbonyl or aryl substituted C1~C10 alkane Oxycarbonyl. The reaction of preparing compound A from compound X can be accomplished in one pot, and intermediates XI and XII can be carried out without isolation.
上述制备化合物A的方法中,所述的与E进行缩合反应的条件可以是在不加催化剂的情况下直接将底物与E混合,在常温或加热条件下进行反应。所述的还原条件可以是:在氢化催化剂存在条件下,通入氢气进行反应,氢化催化剂可以为钯碳、活性镍或PtO2;也可以是:加入还原剂,例如加入铁粉、锌粉或氯化亚锡。由化合物VI制备化合物A可以是在还原剂存在的条件下还原和环合反应一步完成,无需分离中间体VII;由化合物VIII制备化合物A可以是将化合物VIII与E混合,在常温或加热条件下缩合和环合反应一步完成,无需分离中间体VII和/或IX。化合物X是由化合物VIII与含R8取代基的酸酐或卤代物进行常规的酰化或卤代反应得到。化合物E优选N,N-二甲酰胺二甲缩醛(DMF-DMA)、原甲酸三甲酯或原甲酸三乙酯。In the above method for preparing compound A, the conditions for the condensation reaction with E may be directly mixing the substrate with E without adding a catalyst, and then reacting at normal temperature or under heating conditions. Described reduction condition can be: in the presence condition of hydrogenation catalyst, pass into hydrogen to react, hydrogenation catalyst can be palladium carbon, active nickel or PtO 2 ; Also can be: add reducing agent, for example add iron powder, zinc powder or stannous chloride. Compound A can be prepared from compound VI by reducing and ring-closing in one step in the presence of a reducing agent, without the need to separate intermediate VII; by compound VIII, compound A can be prepared by mixing compound VIII and E, at normal temperature or under heating The condensation and cyclization reactions are accomplished in one step without isolation of intermediates VII and/or IX. Compound X is obtained by conventional acylation or halogenation reaction of compound VIII with acid anhydride or halide containing R 8 substituent. Compound E is preferably N,N-dimethylformamide dimethyl acetal (DMF-DMA), trimethyl orthoformate or triethyl orthoformate.
上述制备化合物A的方法中,优选的还原条件为:在氢化催化剂存在条件下,通入氢气进行反应,氢化催化剂为钯碳,所用溶剂为醋酸;或者还原条件为:加入还原剂,还原剂是铁粉或锌粉,进一步加入氯化钙或冰乙酸,所用溶剂为醇或醇-水混合溶剂。In the above-mentioned method for preparing compound A, the preferred reduction condition is: in the presence of a hydrogenation catalyst, feed hydrogen to react, the hydrogenation catalyst is palladium carbon, and the solvent used is acetic acid; or the reduction condition is: add a reducing agent, and the reducing agent is Iron powder or zinc powder, further adding calcium chloride or glacial acetic acid, the solvent used is alcohol or alcohol-water mixed solvent.
本发明还涉及式I所示的6-硝基苯乙酮类化合物的另一用途,其特征在于,式I所示的6-硝基苯乙酮类化合物可按如下方法制备式A’所示化合物,The present invention also relates to another use of the 6-nitroacetophenone compound shown in formula I, characterized in that the 6-nitroacetophenone compound shown in formula I can be prepared as follows: Show compounds,
其中,R1、R2、X和Z的定义同式A化合物。Wherein, the definitions of R 1 , R 2 , X and Z are the same as those of the compound of formula A.
(1)化合物I与化合物E进行缩合反应得到式VI所示化合物,(1) compound I and compound E carry out condensation reaction to obtain the compound shown in formula VI,
其中,Y为-N(R5)2或-OR5,R5、R6和R7相同或不同地选自C1~C10烷基、C1~C10链烯基、芳基和芳基取代的C1~C10烷基中。Wherein, Y is -N(R 5 ) 2 or -OR 5 , R 5 , R 6 and R 7 are the same or different selected from C1~C10 alkyl, C1~C10 alkenyl, aryl and aryl substituted Among C1~C10 alkyl groups.
化合物VI经还原、环合、氯代得到式A’化合物;或者其中中间体化合物VII、化合物A可不经分离直接反应得到式A’化合物;其反应式为:Compound VI is reduced, cyclized, and chlorinated to obtain a compound of formula A'; or wherein intermediate compound VII and compound A can be directly reacted without separation to obtain a compound of formula A'; its reaction formula is:
或者 or
(2)化合物I在还原条件下得到化合物VIII,化合物VIII与化合物E进行缩合反应得到化合物VII和/或化合物IX,化合物VII和/或化合物IX经环合、氯代得到式A’所示化合物;或者中间体化合物VII/化合物IX和化合物A不经分离直接制备式A’所示化合物;其反应式为:(2) Compound I obtains compound VIII under reducing conditions, compound VIII and compound E undergo condensation reaction to obtain compound VII and/or compound IX, compound VII and/or compound IX undergoes cyclization and chlorination to obtain the compound shown in formula A' or intermediate compound VII/compound IX and compound A directly prepare the compound shown in formula A' without separation; its reaction formula is:
或 or
上述制备化合物A’的方法中,所述还原、环合、与E进行缩合反应的条件同上述式A的制备方法。所述氯代反应可采用氯代试剂进行反应,例如采用三氯氧磷、五氯化磷等氯代试剂进行反应。In the above-mentioned method for preparing compound A', the conditions for the reduction, cyclization, and condensation reaction with E are the same as the preparation method of the above-mentioned formula A. The chlorination reaction can be carried out using a chlorinating reagent, for example, using a chlorinating reagent such as phosphorus oxychloride or phosphorus pentachloride.
本发明还提供下式II~XI的化合物:The present invention also provides compounds of the following formulas II to XI:
其中,X为氰基、三氟甲基、硝基、-NHCOR3、-NHCOOR3、-CONR3R3’、-N=CHR3或-CO2R3,其中R3和R3’彼此相同或不同地为氢、C1~C10烷基、C1~C10链烯基、芳基或芳基取代的C1~C10烷基;Z为-NH-、-O-或R1及R1’彼此相同或不同地为甲酰基、C1~C10烷基、C1~C10链烯基、芳基、芳基取代的C1~C10烷基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基;R2为C1~C10烷基、C1~C10链烯基或芳基,所述烷基不必须地被卤素、烷氧基、芳基或者含1~2个O或N的杂环基取代,例如吡咯烷基、哌啶基、吗啉基、哌嗪基、高哌嗪基,其中所述杂环基可不必须地被C1~C10烷基或C1~C10烷氧基取代;且当Z为-O-、R1为甲基时,R2不为甲基;Y为-N(R5)2或-OR5,R5选自C1~C10烷基、C1~C10链烯基、芳基和芳基取代的C1~C10烷基中;R8可以为一般的氨基保护基,即甲酰基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基。Wherein, X is cyano, trifluoromethyl, nitro, -NHCOR 3 , -NHCOOR 3 , -CONR 3 R 3 ', -N=CHR 3 or -CO 2 R 3 , wherein R 3 and R 3 ' are mutually The same or different hydrogen, C1~C10 alkyl, C1~C10 alkenyl, aryl or C1~C10 alkyl substituted by aryl; Z is -NH-, -O- or R 1 and R 1 ' are the same or different from each other as formyl, C1-C10 alkyl, C1-C10 alkenyl, aryl, aryl-substituted C1-C10 alkyl, C1-C10 alkanoyl, aroyl, Aryl substituted C1~C10 alkanoyl, C1~C10 alkoxycarbonyl or aryl substituted C1~C10 alkoxycarbonyl; R2 is C1~C10 alkyl, C1~C10 alkenyl or aryl, so The alkyl group is not necessarily substituted by halogen, alkoxy, aryl or heterocyclic group containing 1 to 2 O or N, such as pyrrolidinyl, piperidinyl, morpholinyl, piperazinyl, homopiperazine group, wherein the heterocyclic group may be optionally substituted by C1~C10 alkyl or C1~C10 alkoxy; and when Z is -O-, R 1 is methyl, R 2 is not methyl; Y is -N(R 5 ) 2 or -OR 5 , R 5 is selected from C1~C10 alkyl, C1~C10 alkenyl, aryl and C1~C10 alkyl substituted by aryl; R 8 can be a general amino group The protecting group is formyl, C1-C10 alkanoyl, aroyl, C1-C10 alkanoyl substituted by aryl, C1-C10 alkoxycarbonyl or C1-C10 alkoxycarbonyl substituted by aryl.
以上化合物中,R1优选为C1~C5烷基、乙酰基、丙酰基、苯甲酰基、叔丁氧羰基、苄基、苄氧羰基或三苯甲基;R2优选为甲基、乙基、丙基、苄基、-(CH2)n-Cl、-(CH2)n-Br、或其中n=1~5,Alkyl为C1~C5烷基;X优选为氰基、三氟甲基、-NHCOOR3、-NHCOOR3、-N=CHR3、C1~C10烷氧羰基或羧基;Z优选为-NH-或-O-;Y优选-N(CH3)2、-OCH3、OC2H5;R8优选乙酰基、叔丁氧羰基、苄氧羰基。Among the above compounds, R1 is preferably C1~C5 alkyl, acetyl, propionyl, benzoyl, tert-butoxycarbonyl, benzyl, benzyloxycarbonyl or trityl; R2 is preferably methyl, ethyl , Propyl, Benzyl, -(CH 2 )n-Cl, -(CH 2 )n-Br, or Where n=1~5, Alkyl is C1~C5 alkyl; X is preferably cyano, trifluoromethyl, -NHCOOR 3 , -NHCOOR 3 , -N=CHR 3 , C1~C10 alkoxycarbonyl or carboxyl; Z Preferably -NH- or -O-; Y is preferably -N(CH 3 ) 2 , -OCH 3 , OC 2 H 5 ; R 8 is preferably acetyl, tert-butoxycarbonyl, benzyloxycarbonyl.
以上化合物进一步优选为:The above compounds are further preferably:
式II化合物优选:Compounds of formula II are preferably:
3’-乙酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮;3'-acetamido-4'-ethoxy-6'-nitro-2-bromoacetophenone;
3’-苯甲酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮;3'-benzamido-4'-ethoxy-6'-nitro-2-bromoacetophenone;
3’-苄胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮;3'-Benzylamino-4'-ethoxy-6'-nitro-2-bromoacetophenone;
3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-硝基-2-溴苯乙酮;3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-nitro-2-bromoacetophenone;
式III化合物优选:Compounds of formula III are preferably:
3’-乙酰胺基-4’-乙氧基-2-溴苯乙酮;3'-acetamido-4'-ethoxy-2-bromoacetophenone;
3’-苯甲酰胺基-4’-乙氧基-2-溴苯乙酮;3'-benzamido-4'-ethoxy-2-bromoacetophenone;
3’-苄胺基-4’-乙氧基-2-溴苯乙酮;3'-Benzylamino-4'-ethoxy-2-bromoacetophenone;
3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-2-溴苯乙酮;3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-2-bromoacetophenone;
式IV化合物优选:Compounds of formula IV are preferably:
3’-乙酰胺基-4’-乙氧基-2-氰基苯乙酮;3'-acetamido-4'-ethoxy-2-cyanoacetophenone;
3’-苯甲酰胺基-4’-乙氧基-2-氰基苯乙酮;3'-benzamido-4'-ethoxy-2-cyanoacetophenone;
3’-苄胺基-4’-乙氧基-2-氰基苯乙酮;3'-Benzylamino-4'-ethoxy-2-cyanoacetophenone;
3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-2-氰基苯乙酮;3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-2-cyanoacetophenone;
式V化合物优选:Compounds of formula V are preferably:
3-(5-乙酰胺基-4-乙氧基-2-硝基苯基)-2-氰基-3-羰基-丙酸乙酯;3-(5-acetamido-4-ethoxy-2-nitrophenyl)-2-cyano-3-carbonyl-propionic acid ethyl ester;
2-(5-乙酰氨基-4-乙氧基-2-硝基苯甲酰基)丙二酸二乙酯;Diethyl 2-(5-acetylamino-4-ethoxy-2-nitrobenzoyl)malonate;
式VI化合物优选:Compounds of formula VI are preferably:
N-(5-(2-氰基-3-(二甲基胺基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺;N-(5-(2-cyano-3-(dimethylamino)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide;
N-(5-(2-氰基-3-(甲氧基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺;N-(5-(2-cyano-3-(methoxy)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide;
N-(5-(2-乙氧基羰基-3-(二甲基胺基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺;N-(5-(2-ethoxycarbonyl-3-(dimethylamino)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide;
式VIII化合物优选:Compounds of formula VIII are preferably:
3’-乙酰胺基-4’-乙氧基-6’-氨基-2-氰基苯乙酮;3'-acetamido-4'-ethoxy-6'-amino-2-cyanoacetophenone;
3’-苯甲酰胺基-4’-乙氧基-6’-氨基-2-氰基苯乙酮;3'-benzamido-4'-ethoxy-6'-amino-2-cyanoacetophenone;
3’-苄胺基-4’-乙氧基-6’-氨基-2-氰基苯乙酮;3'-Benzylamino-4'-ethoxy-6'-amino-2-cyanoacetophenone;
3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-氨基-2-氰基苯乙酮。3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-amino-2-cyanoacetophenone.
本发明实现的技术效果如下:The technical effect that the present invention realizes is as follows:
(1)在本发明中,用化合物I制备化合物A及A’的方法,相对于已有的喹啉环的制备的文献方法,可以避免使用高温条件,避免使用高沸点溶剂,环保而且安全。特别的,X=氰基或酯基时收率达到80%以上,明显优于现有的方法。(1) In the present invention, the method for preparing compound A and A' with compound I, compared to the literature method of the preparation of existing quinoline ring, can avoid using high temperature conditions, avoid using high boiling point solvent, environmental protection and safety. In particular, when X=cyano group or ester group, the yield can reach more than 80%, which is obviously superior to the existing methods.
(2)化合物I可由工业原料很方便、高产率地得到。(2) Compound I can be obtained from industrial raw materials conveniently and in high yield.
(3)反应的转化率高,操作简便,且反应条件温和。多步中间体不需分离纯化,可直接用于下步反应,极大地提高了收率,简化了操作。可以实现工业化生产。(3) The conversion rate of the reaction is high, the operation is simple and convenient, and the reaction conditions are mild. The multi-step intermediate does not need to be separated and purified, and can be directly used in the next step reaction, which greatly improves the yield and simplifies the operation. Industrialized production can be realized.
(4)在用化合物I制备化合物A或A’的方法中,优选方法(2),其反应条件温和,中间体稳定,更易纯化,收率较高,且成本大大降低。制备目标物A或A’的反应产生的杂质少,产物容易纯化,操作简便,总收率较高,更易实现工业化生产。(4) In the method for preparing compound A or A' with compound I, preferred method (2) has mild reaction conditions, stable intermediates, easier purification, higher yield, and greatly reduced cost. The reaction to prepare the target substance A or A' produces less impurities, the product is easy to purify, the operation is simple, the total yield is high, and it is easier to realize industrial production.
总之,通过本发明,实现了3-取代-4-羟基喹啉类化合物和3-取代-4-氯喹啉类化合物的全新的合成路线,条件温和,操作简易,安全有效。In a word, through the present invention, a brand-new synthetic route of 3-substituted-4-hydroxyquinoline compounds and 3-substituted-4-chloroquinoline compounds is realized, with mild conditions, simple operation, safe and effective.
具体实施方式 Detailed ways
通过以下实施例进一步说明本发明,以下实施例仅用于更具体说明本发明的优选实施方式,不用于对本发明的技术方案进行限定。上述本发明的技术方案均为可实现本发明目的的技术方案。即以下实施例所采用温度和试剂,均可用上文所述相应温度和试剂替代以实现本发明的目的。The present invention is further illustrated by the following examples, which are only used to more specifically illustrate preferred embodiments of the present invention, and are not intended to limit the technical solutions of the present invention. The above-mentioned technical solutions of the present invention are all technical solutions that can realize the purpose of the present invention. That is, the temperature and reagents used in the following examples can be replaced by the corresponding temperatures and reagents described above to achieve the purpose of the present invention.
下述制备例中,核磁共振由Bruker AMX-400型和INVOA-600型核磁共振仪测定,TMS为内标,化学位移单位为ppm;质谱由MAT-711型和MAT-95型质谱仪测定;柱层析用硅胶200-300目,青岛海洋化工厂生产;TLC硅胶板为烟台化工厂生产的HSGF-254型薄层层析预制板;石油醚沸程为60-90℃;采用紫外灯,碘缸显色。制备例中若未特别指出操作方法,所述浓缩指用旋转蒸发仪将制备化合物溶液中的溶剂蒸出;所述干燥指用DHG-9240A恒温干燥箱在60℃将制备化合物烘干。In the following preparation examples, nuclear magnetic resonance is measured by Bruker AMX-400 type and INVOA-600 type nuclear magnetic resonance instrument, TMS is an internal standard, and the chemical shift unit is ppm; Mass spectrum is measured by MAT-711 type and MAT-95 type mass spectrometer; The silica gel for column chromatography is 200-300 mesh, produced by Qingdao Ocean Chemical Factory; the TLC silica gel plate is the HSGF-254 thin layer chromatography prefabricated plate produced by Yantai Chemical Factory; the boiling range of petroleum ether is 60-90°C; Iodine cylinder color. If the operation method is not specified in the preparation examples, the concentration refers to evaporating the solvent in the solution of the prepared compound with a rotary evaporator; the drying refers to drying the prepared compound at 60° C. with a DHG-9240A constant temperature drying oven.
实施例一3-乙酰胺基-4-乙氧基苯乙酮(化合物B,R1=乙酰基,R2=乙基,Z=-NH-)的合成Example 1 Synthesis of 3-acetamido-4-ethoxyacetophenone (compound B, R 1 = acetyl, R 2 = ethyl, Z = -NH-)
(1)3-硝基-4-羟基苯乙酮的制备(1) Preparation of 3-nitro-4-hydroxyacetophenone
冰浴中,将对羟基苯乙酮(136.2g,1.0mol)加入到浓硫酸(1000ml)中,搅拌10min,加入硝酸钾(103.0g,1.02mol),搅拌2h,反应结束。将反应液倒入3000ml碎冰中,析出大量固体,抽滤,水洗,干燥,得淡黄色粉末的3-硝基-4-羟基苯乙酮171.2g,收率94.5%。In an ice bath, p-hydroxyacetophenone (136.2 g, 1.0 mol) was added to concentrated sulfuric acid (1000 ml), stirred for 10 min, potassium nitrate (103.0 g, 1.02 mol) was added, stirred for 2 h, and the reaction was completed. The reaction solution was poured into 3000ml of crushed ice, a large amount of solid was precipitated, suction filtered, washed with water, and dried to obtain 171.2g of 3-nitro-4-hydroxyacetophenone as light yellow powder with a yield of 94.5%.
(2)3-氨基-4-羟基苯乙酮的制备(2) Preparation of 3-amino-4-hydroxyacetophenone
常温下,将3-硝基-4-羟基苯乙酮(171.2g,0.945mol)溶于THF(1500ml)中,加入Raney Ni 20g,常压氢化反应24h,反应结束。过滤,浓缩,干燥,得黄褐色固体的3-氨基-4-羟基苯乙酮132.8g,收率93.0%。At room temperature, 3-nitro-4-hydroxyacetophenone (171.2g, 0.945mol) was dissolved in THF (1500ml), and Raney Ni 20g was added, hydrogenated at normal pressure for 24h, and the reaction was completed. Filter, concentrate, and dry to obtain 132.8 g of 3-amino-4-hydroxyacetophenone as a yellow-brown solid, with a yield of 93.0%.
(3)3-乙酰胺基-4-羟基苯乙酮的制备(3) Preparation of 3-acetamido-4-hydroxyacetophenone
将3-氨基-4-羟基苯乙酮(121.0g,0.8mol)溶于冰乙酸(1000ml)中,60℃搅拌,滴加乙酸酐(115.0ml,1.2mol),1h加完,再搅拌30min,反应结束。将反应液倒入2000ml冰水中,析出大量固体,搅拌放置2h,抽滤,水洗,干燥,得黄褐色粉末的3-乙酰胺基-4-羟基苯乙酮134.8g,收率87.2%。Dissolve 3-amino-4-hydroxyacetophenone (121.0g, 0.8mol) in glacial acetic acid (1000ml), stir at 60°C, add acetic anhydride (115.0ml, 1.2mol) dropwise, add 1h, then stir for 30min , the reaction ends. The reaction solution was poured into 2000ml of ice water, a large amount of solid precipitated out, stirred for 2 hours, suction filtered, washed with water, and dried to obtain 134.8g of 3-acetamido-4-hydroxyacetophenone as a yellowish brown powder with a yield of 87.2%.
(4)3-乙酰胺基-4-乙氧基苯乙酮的制备(4) Preparation of 3-acetamido-4-ethoxyacetophenone
将3-乙酰胺基-4-羟基苯乙酮(96.6g,0.5mol)和碳酸钾(138.2g,1.0mol)溶于DMF(500ml)中,60℃搅拌10min,滴加溴乙烷(60ml,0.75mol),1h加完,再搅拌30min,反应结束。将反应液倒入2000ml冰水中,用乙酸乙酯提取(600ml×4),水洗有机层,干燥,浓缩得灰褐色粉末的3-乙酰胺基-4-乙氧基苯乙酮(化合物B,R1=乙酰基,R2=乙基,Z=-NH-)100.9g,收率91.2%。1HNMR(300MHz,CDCl3)δ1.49(t,3H),2.22(s,3H),2.56(s,3H),4.19(q,2H),6.90(d,1H),7.74(m,2H),8.96(s,1H)。ESI-MS(m/z)222(M+1),244(M+23),260(M+39)。Dissolve 3-acetamido-4-hydroxyacetophenone (96.6g, 0.5mol) and potassium carbonate (138.2g, 1.0mol) in DMF (500ml), stir at 60°C for 10min, add bromoethane (60ml , 0.75mol), 1h added, and then stirred for 30min, the reaction ended. The reaction solution was poured into 2000ml ice water, extracted with ethyl acetate (600ml×4), the organic layer was washed with water, dried, and concentrated to obtain 3-acetamido-4-ethoxyacetophenone (compound B, R 1 = acetyl, R 2 = ethyl, Z = -NH-) 100.9 g, yield 91.2%. 1 HNMR (300MHz, CDCl 3 ) δ1.49(t, 3H), 2.22(s, 3H), 2.56(s, 3H), 4.19(q, 2H), 6.90(d, 1H), 7.74(m, 2H ), 8.96(s, 1H). ESI-MS (m/z) 222 (M+1), 244 (M+23), 260 (M+39).
实施例二3-乙酰胺基-4-乙氧基-6-硝基苯乙酮(化合物D,R1=乙酰基,R2=乙基,Z=-NH-)的合成Example 2 Synthesis of 3-acetamido-4-ethoxy-6-nitroacetophenone (compound D, R 1 = acetyl, R 2 = ethyl, Z = -NH-)
将化合物B(R1=乙酰基,R2=乙基,Z=-NH-)(88.5g,0.4mol)溶于硝基甲烷(1000ml)中,加入发烟硝酸(17.7ml,0.4mol),于40℃搅拌12h,补加发烟硝酸(15.5ml,0.35mol),搅拌10h,反应结束。将反应液倒入饱和碳酸氢钠溶液(1000ml)中,搅拌,分液,水洗有机层,干燥,过滤,滤液中加入10g活性炭,回流20min,热滤,浓缩得红色油状物,40℃常压干燥得淡红色固体的3-乙酰胺基-4-乙氧基-6-硝基苯乙酮(化合物D,R1=乙酰基,R2=乙基,Z=-NH-)86.5g,收率81.2%。1HNMR(300MHz,CDCl3)δ1.52(t,3H),2.24(s,3H),2.52(s,3H),4.22(q,2H),7.53(s,1H),7.98(s,1H),8.52(s,1H)。ESI-MS(m/z)265(M-1)。Compound B (R 1 =acetyl, R 2 =ethyl, Z=-NH-) (88.5g, 0.4mol) was dissolved in nitromethane (1000ml), and fuming nitric acid (17.7ml, 0.4mol) was added , stirred at 40°C for 12h, added fuming nitric acid (15.5ml, 0.35mol), stirred for 10h, and the reaction ended. Pour the reaction solution into saturated sodium bicarbonate solution (1000ml), stir, separate liquids, wash the organic layer with water, dry, filter, add 10g of activated carbon to the filtrate, reflux for 20min, heat filter, concentrate to obtain a red oily substance, 40°C under normal pressure 86.5 g of 3-acetamido-4-ethoxy-6-nitroacetophenone (compound D, R 1 = acetyl, R 2 = ethyl, Z = -NH-) was dried as a light red solid, Yield 81.2%. 1 HNMR (300MHz, CDCl 3 ) δ1.52(t, 3H), 2.24(s, 3H), 2.52(s, 3H), 4.22(q, 2H), 7.53(s, 1H), 7.98(s, 1H ), 8.52(s, 1H). ESI-MS (m/z) 265 (M-1).
实施例三3’-乙酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮(化合物II,R1=乙酰基,R2=乙基,Z=-NH-)的合成Example 3 3'-acetamido-4'-ethoxy-6'-nitro-2-bromoacetophenone (Compound II, R 1 =acetyl, R 2 =ethyl, Z=-NH- )Synthesis
将化合物D(R1=乙酰基,R2=乙基,Z=-NH-)(79.9g,0.3mol)溶于二氯甲烷(1000ml)中,加入液溴(15.7ml,0.306mol),常温搅拌12h,反应液由淡红色变为淡黄色,反应结束。浓缩得淡红色油状物的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮(化合物II,R1=乙酰基,R2=乙基,Z=-NH-)110.0g,可直接用于下一步反应。1HNMR(300MHz,CDCl3)δ1.55(t,3H),2.24(s,3H),4.27(q,2H),4.30(s,2H),7.64(s,1H),8.01(s,1H),8.58(s,1H)。ESI-MS(m/z)346(M+1),368(M+23)。Compound D (R 1 = acetyl, R 2 = ethyl, Z = -NH-) (79.9 g, 0.3 mol) was dissolved in dichloromethane (1000 ml), liquid bromine (15.7 ml, 0.306 mol) was added, After stirring at room temperature for 12 hours, the reaction solution changed from light red to light yellow, and the reaction was completed. 3'-acetamido-4'-ethoxy-6'-nitro-2-bromoacetophenone (compound II, R 1 = acetyl, R 2 = ethyl, Z =-NH-) 110.0g, can be directly used in the next reaction. 1 HNMR (300MHz, CDCl 3 ) δ1.55(t, 3H), 2.24(s, 3H), 4.27(q, 2H), 4.30(s, 2H), 7.64(s, 1H), 8.01(s, 1H ), 8.58(s, 1H). ESI-MS (m/z) 346 (M+1), 368 (M+23).
实施例四3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 4 3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano , Z=-NH-) synthesis
将化合物II(R1=乙酰基,R2=乙基,Z=-NH-)(110.0g,0.3mol)溶于乙醇(600ml)和DMSO(200ml)中,冰浴冷却,滴加氰化钠(29.4g,0.6mol)的水(300ml)溶液,1h加完,反应液呈黑褐色,常温反应6h,反应结束。将反应液倒入2000ml水中,用1M盐酸调溶液pH值为5,析出大量固体,抽滤,水洗,干燥,得灰黄色粉末的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)68.3g,收率78.2%。1HNMR(300MHz,CDCl3)δ1.56(t,3H),2.28(s,3H),3.85(s,2H),4.28(q,2H),7.64(s,1H),8.02(s,1H),8.58(s,1H)。ESI-MS(m/z)290(M-1)。Compound II (R 1 = acetyl, R 2 = ethyl, Z = -NH-) (110.0 g, 0.3 mol) was dissolved in ethanol (600 ml) and DMSO (200 ml), cooled in an ice bath, and cyanide was added dropwise Sodium (29.4g, 0.6mol) in water (300ml) solution was added after 1 hour, and the reaction solution was dark brown. After 6 hours at room temperature, the reaction was completed. Pour the reaction solution into 2000ml of water, adjust the pH value of the solution to 5 with 1M hydrochloric acid, precipitate a large amount of solid, suction filter, wash with water, and dry to obtain 3'-acetamido-4'-ethoxy-6' as grayish yellow powder -Nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 68.3 g, yield 78.2%. 1 HNMR (300MHz, CDCl 3 ) δ1.56(t, 3H), 2.28(s, 3H), 3.85(s, 2H), 4.28(q, 2H), 7.64(s, 1H), 8.02(s, 1H ), 8.58(s, 1H). ESI-MS (m/z) 290 (M-1).
实施例五 N-(5-(2-氰基-3-(二甲基胺基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺(化合物VI,R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)的合成Example 5 N-(5-(2-cyano-3-(dimethylamino)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide (compound VI, R 1 =acetyl group, R 2 = ethyl, X = cyano, Y = -N(CH 3 ) 2 , Z = -NH-)
将化合物I(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(58.3g,0.2mol)溶于乙二醇二甲醚(600ml)中,加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(29.2ml,0.22mol),室温搅拌,反应液中逐渐析出淡黄色粉末,1h后反应结束。抽滤,洗涤,干燥,得淡黄色粉末的N-(5-(2-氰基-3-(二甲基胺基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺(化合物VI,R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)93.0g,收率91.0%。1HNMR(300MHz,DMSO)δ1.43(t,3H),2.17(s,3H),3.27(s,3H),3.31(s,3H),4.28(q,2H),7.73(s,1H),8.26(s,1H),9.52(s,1H)。ESI-MS(m/z)345(M-1)。Compound I (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (58.3 g, 0.2 mol) was dissolved in ethylene glycol dimethyl ether (600 ml), N was added, N-Diformamide dimethyl acetal (DMF-DMA) (29.2ml, 0.22mol) was stirred at room temperature, a light yellow powder gradually precipitated out of the reaction solution, and the reaction ended after 1h. Suction filtration, washing, and drying to obtain N-(5-(2-cyano-3-(dimethylamino)acryloyl)-2-ethoxy-4-nitrophenyl)ethane as light yellow powder Amide (compound VI, R 1 = acetyl, R 2 = ethyl, X = cyano, Y = -N(CH 3 ) 2 , Z = -NH-) 93.0 g, yield 91.0%. 1 HNMR (300MHz, DMSO) δ1.43(t, 3H), 2.17(s, 3H), 3.27(s, 3H), 3.31(s, 3H), 4.28(q, 2H), 7.73(s, 1H) , 8.26(s, 1H), 9.52(s, 1H). ESI-MS (m/z) 345 (M-1).
实施例六 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 6 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH -)Synthesis
将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)(34.6g,0.1mol)溶于DMF(300ml),加入Raney Ni 6g,常压氢化反应3h,反应结束。过滤,滤液浓缩至一半体积,再用水(600ml)稀释,析出固体,室温放置过夜,抽滤,水洗,干燥,得淡黄色粉末的6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)16.6g,收率61%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Compound VI (R 1 = acetyl, R 2 = ethyl, X = cyano, Y = -N(CH 3 ) 2 , Z = -NH-) (34.6 g, 0.1 mol) was dissolved in DMF (300 ml) , add Raney Ni 6g, hydrogenation reaction at normal pressure for 3h, and the reaction ends. Filtrate, concentrate the filtrate to half its volume, then dilute with water (600ml) to precipitate a solid, leave it overnight at room temperature, filter with suction, wash with water, and dry to obtain 6-acetamido-7-ethoxy-3-cyano as a light yellow powder - 4-Hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 16.6 g, yield 61%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).
实施例七 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 7 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH -)Synthesis
将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)(5.0g,0.0144mol)溶于DMF(60ml)和乙醇(10ml),加入氯化钙(7.2g,0.0648mol)的水(10ml)溶液,加入还原铁粉(3.6g,0.0648mol),75℃反应,6h后反应结束,加入活性炭(0.5g),于75℃脱色20min。抽滤,滤液浓缩至一半体积,滤液倒入碎冰(100g)中,放置1h,析出土黄色固体,抽滤,水洗,干燥得土黄色固体6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)3.1g,收率79%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Compound VI (R 1 = acetyl, R 2 = ethyl, X = cyano, Y = -N(CH 3 ) 2 , Z = -NH-) (5.0 g, 0.0144 mol) was dissolved in DMF (60 ml) and ethanol (10ml), add calcium chloride (7.2g, 0.0648mol) in water (10ml) solution, add reduced iron powder (3.6g, 0.0648mol), react at 75°C, after 6h the reaction is over, add activated carbon (0.5g ), decolorize at 75°C for 20min. Suction filtration, the filtrate was concentrated to half volume, the filtrate was poured into crushed ice (100g), and left for 1h, a khaki solid was precipitated, suction filtered, washed with water, and dried to obtain a khaki solid 6-acetamido-7-ethoxy-3 -Cyano-4-hydroxyquinoline (compound A, R 1 =acetyl, R 2 =ethyl, X = cyano, Z = -NH-) 3.1 g, yield 79%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).
实施例八 N-(5-(2-氰基-3-(甲氧基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺(化合物VI,R1=乙酰基,R2=乙基,X=氰基,Y=-OCH3,Z=-NH-)的合成Example 8 N-(5-(2-cyano-3-(methoxy)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide (compound VI, R 1 =acetyl, Synthesis of R 2 = ethyl, X = cyano, Y = -OCH 3 , Z = -NH-)
将化合物I(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(58.3g,0.2mol)悬浮于乙二醇二甲醚(600ml)中,加入原甲酸三甲酯(化合物E,Y=OCH3)(63.6g,0.6mol),通氮气保护,加热回流,5-6h反应结束。蒸出溶剂得棕黄色固体,用乙酸乙酯/石油醚重结晶,得淡黄色粉末的N-(5-(2-氰基-3-(甲氧基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺(化合物VI,R1=乙酰基,R2=乙基,X=氰基,Y=-OCH3,Z=-NH-)50.2g,收率81%。1HNMR(300MHz,DMSO)δ1.46(t,3H),2.18(s,3H),4.12(s,3H),4.31(q,2H),7.81(s,1H),8.13(s,1H),8.30(s,1H),9.64(s,1H)。ESI-MS(m/z)334(M+1)。Compound I (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (58.3 g, 0.2 mol) was suspended in ethylene glycol dimethyl ether (600 ml), and orthoformic acid was added Trimethyl ester (compound E, Y=OCH 3 ) (63.6 g, 0.6 mol) was protected by nitrogen gas, heated to reflux, and the reaction was completed within 5-6 hours. The solvent was distilled off to obtain a brownish-yellow solid, which was recrystallized from ethyl acetate/petroleum ether to obtain N-(5-(2-cyano-3-(methoxy)acryloyl)-2-ethoxy -4-nitrophenyl)acetamide (Compound VI, R 1 =acetyl, R 2 =ethyl, X = cyano, Y = -OCH 3 , Z = -NH-) 50.2g, yield 81% . 1 HNMR (300MHz, DMSO) δ1.46(t, 3H), 2.18(s, 3H), 4.12(s, 3H), 4.31(q, 2H), 7.81(s, 1H), 8.13(s, 1H) , 8.30(s, 1H), 9.64(s, 1H). ESI-MS (m/z) 334 (M+1).
实施例九 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 9 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH -)Synthesis
将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-OCH3,Z=-NH-)(30.5g,0.1mol)溶于DMF(300ml),加入Raney Ni 6g,常压氢化反应4h,反应结束。过滤,滤液浓缩至一半体积,再用水(600ml)稀释,析出白色固体,室温放置过夜,抽滤,水洗,干燥,得淡黄色粉末的6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)20.5g,收率76%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Compound VI (R 1 = acetyl, R 2 = ethyl, X = cyano, Y = -OCH 3 , Z = -NH-) (30.5 g, 0.1 mol) was dissolved in DMF (300 ml), and Raney Ni 6g, atmospheric pressure hydrogenation reaction 4h, the reaction is over. Filtrate, concentrate the filtrate to half its volume, and then dilute with water (600ml) to precipitate a white solid, leave it overnight at room temperature, filter with suction, wash with water, and dry to obtain 6-acetamido-7-ethoxy-3-cyanide as a pale yellow powder 20.5 g of 4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-), yield 76%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).
实施例十 3’-乙酰胺基-4’-乙氧基-2-溴苯乙酮(化合物III,R1=乙酰基,R2=乙基,Z=-NH-)的合成Example 10 Synthesis of 3'-acetamido-4'-ethoxy-2-bromoacetophenone (compound III, R 1 = acetyl, R 2 = ethyl, Z = -NH-)
将化合物B(R1=乙酰基,R2=乙基,Z=-NH-)(66.4g,0.3mol)溶于二氯甲烷(1000ml)中,加入液溴(15.7ml,0.306mol),常温搅拌2h,反应液中析出灰色固体,反应结束。浓缩反应液至300mL,抽滤、洗涤、干燥,得灰色固体的3’-乙酰胺基-4’-乙氧基-2-溴苯乙酮(化合物III,R1=乙酰基,R2=乙基,Z=-NH-)98.0g,产率80%。1HNMR(300MHz,CDCl3)δ1.56(t,3H),2.28(s,3H),3.85(s,2H),4.28(q,2H),7.64(s,1H),8.02(s,1H),8.58(s,1H)。EI-MS(m/z)300(M+),299(M-1)。Compound B (R 1 =acetyl, R 2 =ethyl, Z=-NH-) (66.4g, 0.3mol) was dissolved in dichloromethane (1000ml), liquid bromine (15.7ml, 0.306mol) was added, After stirring at room temperature for 2 h, a gray solid precipitated out of the reaction solution, and the reaction was completed. Concentrate the reaction solution to 300 mL, suction filter, wash, and dry to obtain 3'-acetamido-4'-ethoxy-2-bromoacetophenone (compound III, R 1 = acetyl, R 2 = Ethyl, Z=-NH-) 98.0 g, yield 80%. 1 HNMR (300MHz, CDCl 3 ) δ1.56(t, 3H), 2.28(s, 3H), 3.85(s, 2H), 4.28(q, 2H), 7.64(s, 1H), 8.02(s, 1H ), 8.58(s, 1H). EI-MS (m/z) 300 (M + ), 299 (M-1).
实施例十一 3’-乙酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮(化合物II,R1=乙酰基,R2=乙基,Z=-NH-)的合成Example 11 3'-acetamido-4'-ethoxy-6'-nitro-2-bromoacetophenone (compound II, R 1 = acetyl, R 2 = ethyl, Z = -NH -)Synthesis
将化合物III(R1=乙酰基,R2=乙基,Z=-NH-)(98.0g,0.3mol)溶于硝基甲烷(1000ml)中,加入发烟硝酸(15.1ml,0.36mol),于40℃搅拌5h,补加发烟硝酸(13.3ml,0.3mol),搅拌2h,反应结束。将反应液倒入饱和碳酸氢钠溶液(1000ml)中,搅拌,水洗有机层,干燥,过滤,滤液中加入10g活性炭,回流20min,热滤,浓缩得褐色油状物,40℃常压干燥得褐色固体的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮(化合物II,R1=乙酰基,R2=乙基,Z=-NH-)86.1g,收率83.2%。1HNMR(300MHz,CDCl3)δ1.55(t,3H),2.24(s,3H),4.27(q,2H),4.30(s,2H),7.64(s,1H),8.01(s,1H),8.58(s,1H)。ESI-MS(m/z)346(M+1),368(M+23)。Compound III (R 1 = acetyl, R 2 = ethyl, Z = -NH-) (98.0 g, 0.3 mol) was dissolved in nitromethane (1000 ml), and fuming nitric acid (15.1 ml, 0.36 mol) was added , stirred at 40°C for 5h, added fuming nitric acid (13.3ml, 0.3mol), stirred for 2h, and the reaction ended. Pour the reaction solution into saturated sodium bicarbonate solution (1000ml), stir, wash the organic layer with water, dry, filter, add 10g of activated carbon to the filtrate, reflux for 20min, heat filter, concentrate to obtain a brown oil, dry at 40°C under normal pressure to obtain a brown Solid 3'-acetamido-4'-ethoxy-6'-nitro-2-bromoacetophenone (compound II, R 1 = acetyl, R 2 = ethyl, Z = -NH-) 86.1 g, yield 83.2%. 1 HNMR (300MHz, CDCl 3 ) δ1.55(t, 3H), 2.24(s, 3H), 4.27(q, 2H), 4.30(s, 2H), 7.64(s, 1H), 8.01(s, 1H ), 8.58(s, 1H). ESI-MS (m/z) 346 (M+1), 368 (M+23).
实施例十二 3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 12 3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano base, Z=-NH-) synthesis
将化合物II(R1=乙酰基,R2=乙基,Z=-NH-)(110.0g,0.3mol)溶于乙醇(600ml)和DMSO(200ml)中,固体未全溶,冰浴冷却,滴加氰化钠(29.4g,0.6mol)的水(300ml)溶液,1h加完,常温反应6h,反应结束。将反应液倒入2000ml水中,用1M盐酸调溶液pH值为5,析出大量固体,抽滤,水洗,干燥,得淡黄色粉末的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)68.3g,收率80%。1HNMR(300MHz,CDCl3)δ1.56(t,3H),2.28(s,3H),3.85(s,2H),4.28(q,2H),7.64(s,1H),8.02(s,1H),8.58(s,1H)。Compound II (R 1 = acetyl, R 2 = ethyl, Z = -NH-) (110.0 g, 0.3 mol) was dissolved in ethanol (600 ml) and DMSO (200 ml), the solid was not fully dissolved, cooled in an ice bath , Add a solution of sodium cyanide (29.4g, 0.6mol) in water (300ml) dropwise, finish adding in 1h, react at room temperature for 6h, and the reaction ends. Pour the reaction solution into 2000ml of water, adjust the pH value of the solution to 5 with 1M hydrochloric acid, precipitate a large amount of solid, suction filter, wash with water, and dry to obtain 3'-acetamido-4'-ethoxy-6' as light yellow powder -Nitro-2-cyanoacetophenone (compound I, R 1 =acetyl, R2 = ethyl, X = cyano, Z = -NH-) 68.3 g, yield 80%. 1 HNMR (300MHz, CDCl 3 ) δ1.56(t, 3H), 2.28(s, 3H), 3.85(s, 2H), 4.28(q, 2H), 7.64(s, 1H), 8.02(s, 1H ), 8.58(s, 1H).
实施例十三 3’-乙酰胺基-4’-乙氧基-2-氰基苯乙酮(化合物IV,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 13 3'-acetamido-4'-ethoxy-2-cyanoacetophenone (compound IV, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH -)Synthesis
将化合物III(R1=乙酰基,R2=乙基,Z=-NH-)(98.0g,0.3mol)溶于乙醇(500ml)和DMSO(300ml)中,固体未全溶,冰浴冷却,滴加氰化钠(29.4g,0.6mol)的水(300ml)溶液,1h加完,反应液中的固体逐渐溶解,常温反应2h,反应结束。将反应液倒入2000ml水中,用1M盐酸调溶液pH值为5,析出大量固体,抽滤,水洗,干燥,得淡黄色粉末的3’-乙酰胺基-4’-乙氧基-2-氰基苯乙酮(化合物IV,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)57.0g,收率77.2%。1HNMR(300MHz,DMSO)δ1.38(t,3H),2.11(s,3H),4.22(q,2H),4.67(s,2H),7.18(d,1H),7.70(m,1H),8.54(s,1H),9.17(s,1H)。EI-MS(m/z)246(M+)。Compound III (R 1 = acetyl, R 2 = ethyl, Z = -NH-) (98.0 g, 0.3 mol) was dissolved in ethanol (500 ml) and DMSO (300 ml), the solid was not fully dissolved, cooled in an ice bath , Add a solution of sodium cyanide (29.4g, 0.6mol) in water (300ml) dropwise, after 1h, the solids in the reaction solution gradually dissolve, react at room temperature for 2h, and the reaction ends. The reaction solution was poured into 2000ml of water, and the pH of the solution was adjusted to 5 with 1M hydrochloric acid. A large amount of solid precipitated, filtered with suction, washed with water, and dried to obtain 3'-acetamido-4'-ethoxy-2- Cyanoacetophenone (compound IV, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 57.0 g, yield 77.2%. 1 HNMR (300MHz, DMSO) δ1.38(t, 3H), 2.11(s, 3H), 4.22(q, 2H), 4.67(s, 2H), 7.18(d, 1H), 7.70(m, 1H) , 8.54(s, 1H), 9.17(s, 1H). EI-MS (m/z) 246 (M + ).
实施例十四3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 14 3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano base, Z=-NH-) synthesis
将化合物IV(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(73.8g,0.3mol)溶于硝基甲烷(l000ml)中,加入发烟硝酸(15.1ml,0.36mol),搅拌2h,补加发烟硝酸(13.3ml,0.3mol),搅拌5h,反应结束。将反应液倒入饱和碳酸氢钠溶液(1000ml)中,搅拌,水洗有机层,干燥,过滤,滤液中加入10g活性炭,回流20min,热滤,浓缩,干燥,得到褐色固体的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)71g,产率81%。1HNMR(300MHz,CDCl3)δ1.56(t,3H),2.28(s,3H),3.85(s,2H),4.28(q,2H),7.64(s,1H),8.02(s,1H),8.58(s,1H)。Compound IV (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (73.8 g, 0.3 mol) was dissolved in nitromethane (1000 ml), fuming nitric acid (15.1 ml, 0.36mol), stirred for 2h, added fuming nitric acid (13.3ml, 0.3mol), stirred for 5h, and the reaction ended. Pour the reaction solution into saturated sodium bicarbonate solution (1000ml), stir, wash the organic layer with water, dry, filter, add 10g of activated carbon to the filtrate, reflux for 20min, heat filter, concentrate, and dry to obtain 3'-acetamide as a brown solid Acyl-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 71g , yield 81%. 1 HNMR (300MHz, CDCl 3 ) δ1.56(t, 3H), 2.28(s, 3H), 3.85(s, 2H), 4.28(q, 2H), 7.64(s, 1H), 8.02(s, 1H ), 8.58(s, 1H).
实施例十五 3-(5-乙酰胺基-4-乙氧基-2-硝基苯基)-2-氰基-3-羰基-丙酸乙酯(化合物V,R1=乙酰基,R2=乙基,R4=乙基,X=氰基,Z=-NH-)的合成Example 15 3-(5-acetamido-4-ethoxy-2-nitrophenyl)-2-cyano-3-carbonyl-propionic acid ethyl ester (compound V, R 1 = acetyl, Synthesis of R 2 = ethyl, R 4 = ethyl, X = cyano, Z = -NH-)
将3-胺基-4-羟基苯甲酸甲酯(133.7g,0.8mol)溶于冰乙酸(1000mL)中,60℃搅拌,未全溶,滴加乙酸酐(115.0mL,1.2mol),1h加完,反应结束,析出大量固体。将反应液倒入2000mL冰水中,析出大量固体,搅拌放置1h,抽滤,水洗,干燥,得乳白色固体的3-乙酰胺基-4-羟基苯甲酸甲酯154.3g,收率92.2%。Dissolve 3-amino-4-hydroxybenzoic acid methyl ester (133.7g, 0.8mol) in glacial acetic acid (1000mL), stir at 60°C, if not fully dissolved, add acetic anhydride (115.0mL, 1.2mol) dropwise, 1h After the addition was complete, the reaction ended, and a large amount of solid was precipitated. The reaction solution was poured into 2000 mL of ice water, a large amount of solids were precipitated, stirred for 1 h, filtered with suction, washed with water, and dried to obtain 154.3 g of methyl 3-acetamido-4-hydroxybenzoate as a milky white solid, with a yield of 92.2%.
将3-乙酰胺基-4-羟基苯甲酸甲酯(104.6g,0.5mol)和碳酸钾(138.2g,1.0mol)溶于DMF(500mL)中,60℃搅拌10min,未全溶,滴加溴乙烷(60.0mL,0.75mol),1h加完,反应结束,析出大量固体。将反应液倒入2000mL冰水中,析出大量固体,抽滤,水洗,干燥,得淡粉色固体的3-乙酰胺基-4-乙氧基苯甲酸甲酯112.0g,收率94.5%。1H-NMR(300MHz,CDCl3)δ1.47(t,3H),2.21(s,3H),3.87(s,3H),4.15(q,2H),6.87(d,1H),7.70(s,1H),7.77(dd,1H),8.97(d,1H)。ESI-MS(m/z)238(M+1),260(M+23)。Dissolve methyl 3-acetamido-4-hydroxybenzoate (104.6g, 0.5mol) and potassium carbonate (138.2g, 1.0mol) in DMF (500mL), stir at 60°C for 10min, until they are not completely dissolved, add dropwise Ethyl bromide (60.0 mL, 0.75 mol) was added after 1 h, and the reaction was completed, and a large amount of solids were precipitated. The reaction solution was poured into 2000 mL of ice water, a large amount of solid precipitated out, suction filtered, washed with water, and dried to obtain 112.0 g of methyl 3-acetamido-4-ethoxybenzoate as a pale pink solid, with a yield of 94.5%. 1 H-NMR (300MHz, CDCl 3 ) δ1.47(t, 3H), 2.21(s, 3H), 3.87(s, 3H), 4.15(q, 2H), 6.87(d, 1H), 7.70(s , 1H), 7.77 (dd, 1H), 8.97 (d, 1H). ESI-MS (m/z) 238 (M+1), 260 (M+23).
常温下将3-乙酰胺基-4-乙氧基苯甲酸甲酯(95.0g,0.4mol)溶于硝基甲烷(1500mL)中,加入发烟硝酸(50.0mL,1.2mol),于30℃搅拌3h,反应结束。将反应液倒入碳酸钠(80.0g,0.75mol)水溶液(1200mL)中,搅拌,分液,水洗有机层,干燥,蒸出溶剂得淡红棕色固体的3-乙酰胺基-4-乙氧基-6-硝基苯甲酸甲酯104.0g,收率92.0%。1H-NMR(300MHz,CDCl3)δ1.52(t,3H),2.25(s,3H),3.88(s,3H),4.22(q,2H),7.44(s,1H),7.90(s,1H),8.74(s,1H)。ESI-MS(m/z)283(M+1),305(M+23)。Dissolve methyl 3-acetamido-4-ethoxybenzoate (95.0 g, 0.4 mol) in nitromethane (1500 mL) at room temperature, add fuming nitric acid (50.0 mL, 1.2 mol), and Stirred for 3h, the reaction ended. Pour the reaction solution into sodium carbonate (80.0g, 0.75mol) aqueous solution (1200mL), stir, separate the layers, wash the organic layer with water, dry, evaporate the solvent to obtain 3-acetamido-4-ethoxy 104.0 g of methyl-6-nitrobenzoate, yield 92.0%. 1 H-NMR (300MHz, CDCl 3 ) δ1.52(t, 3H), 2.25(s, 3H), 3.88(s, 3H), 4.22(q, 2H), 7.44(s, 1H), 7.90(s , 1H), 8.74 (s, 1H). ESI-MS (m/z) 283 (M+1), 305 (M+23).
将3-乙酰胺基-4-乙氧基-6-硝基苯甲酸甲酯(85.0g,0.3mol)溶于THF(500mL)和10%氢氧化钠水溶液(500mL,1.3mol),回流反应4h,反应结束。冷却至室温,反应液分层,上层为淡黄色,下层为黑褐色,分液,下层用冰乙酸调pH值为4-5,乙酸乙酯提取(200mL×5次),水洗有机层,干燥,蒸出溶剂得褐色块状固体的3-胺基-4-乙氧基-6-硝基苯甲酸甲酯63.8g,收率94%。直接用于下一步反应。1H-NMR(300MHz,DMSO)δ1.37(t,3H),4.13(q,2H),6.40(s,1H),6.68(s,1H),7.44(s,1H),13.20(bs,1H)。ESI-MS(m/z)227(M+1)。3-Acetamido-4-ethoxy-6-nitrobenzoic acid methyl ester (85.0g, 0.3mol) was dissolved in THF (500mL) and 10% aqueous sodium hydroxide solution (500mL, 1.3mol), reflux reaction 4h, the reaction ended. Cool to room temperature, the reaction solution is layered, the upper layer is light yellow, the lower layer is dark brown, separate the layers, adjust the pH value of the lower layer to 4-5 with glacial acetic acid, extract with ethyl acetate (200mL×5 times), wash the organic layer with water, and dry , the solvent was distilled off to obtain 63.8 g of methyl 3-amino-4-ethoxy-6-nitrobenzoate as a brown blocky solid, with a yield of 94%. used directly in the next reaction. 1 H-NMR (300MHz, DMSO) δ1.37(t, 3H), 4.13(q, 2H), 6.40(s, 1H), 6.68(s, 1H), 7.44(s, 1H), 13.20(bs, 1H). ESI-MS (m/z) 227 (M+1).
将3-胺基-4-乙氧基-6-硝基苯甲酸甲酯(63.8g,0.282mol)溶于冰乙酸(600mL)中,60℃搅拌,滴加乙酸酐(29.0mL,0.3mol),1h加完,反应结束。将反应液倒入冰水(1000mL)中,析出大量灰色粉末,放置1h,抽滤,水洗,干燥,得灰黄色固体的3-乙酰胺基-4-乙氧基-6-硝基苯甲酸63.0g,,收率83%。1H-NMR(300MHz,DMSO)δ1.40(t,3H),2.17(s,3H),4.26(q,2H),7.60(s,1H),8.56(s,1H),9.46(s,1H),13.50(bs,1H)。。ESI-MS(m/z)267(M-1)。Dissolve methyl 3-amino-4-ethoxy-6-nitrobenzoate (63.8g, 0.282mol) in glacial acetic acid (600mL), stir at 60°C, add dropwise acetic anhydride (29.0mL, 0.3mol ), 1h added, the reaction ended. The reaction solution was poured into ice water (1000mL), a large amount of gray powder was precipitated, left for 1h, suction filtered, washed with water, and dried to obtain 3-acetamido-4-ethoxy-6-nitrobenzoic acid as a pale yellow solid 63.0 g, yield 83%. 1 H-NMR (300MHz, DMSO) δ1.40(t, 3H), 2.17(s, 3H), 4.26(q, 2H), 7.60(s, 1H), 8.56(s, 1H), 9.46(s, 1H), 13.50 (bs, 1H). . ESI-MS (m/z) 267 (M-1).
将3-乙酰胺基-4-乙氧基-6-硝基苯甲酸(54.0g,0.2mol)溶于二氯甲烷(300ml)中,未全溶,加入氯化亚砜(58.0ml,0.8mol),回流反应,冷凝管上端放置无水氯化钙干燥管,2h后反应结束,反应液澄清。浓缩得到褐色固体的3-乙酰胺基-4-乙氧基-6-硝基苯甲酰氯。Dissolve 3-acetamido-4-ethoxy-6-nitrobenzoic acid (54.0g, 0.2mol) in dichloromethane (300ml), and add thionyl chloride (58.0ml, 0.8 mol), reflux reaction, anhydrous calcium chloride drying tube is placed on the upper end of the condenser tube, the reaction ends after 2h, and the reaction solution is clarified. Concentration afforded 3-acetamido-4-ethoxy-6-nitrobenzoyl chloride as a brown solid.
将金属钠(9.2g,0.4mol)溶于乙醇(150ml),待钠全溶后再回流反应10min,待反应液冷却至50℃-60℃,滴加氰基乙酸乙酯(47.0ml,0.44mol),10min加完,反应液中生成大量白色粉末,再回流反应30min,而后冰盐浴冷却至-8℃。向反应液中滴加3-乙酰胺基-4-乙氧基-6-硝基苯甲酰氯的无水THF溶液(150ml),1h加完,保持反应温度0℃以下,滴加完毕反应即结束。向反应液中滴加冰水(100ml),保持反应液温度在10℃以下,再向反应液中加入浓硫酸(10ml,0.15mol)的冰水(1000ml)溶液,调反应液pH值为1-2,析出大量固体,搅拌放置1h,抽滤,洗涤,干燥得黄褐色固体的3-(5-乙酰胺基-4-乙氧基-2-硝基苯基)-2-氰基-3-羰基-丙酸乙酯(化合物V,R1=乙酰基,R2=乙基,R4=乙基,X=氰基,Z=-NH-)68.0g,收率93.5%。1HNMR(300MHz,DMSO)δ0.96(t,3H),1.43(t,3H),2.20(s,3H),3.86(q,2H),4.28(q,2H),7.79(s,1H),8.14(s,1H),9.51(s,1H)。ESI-Ms(m/z)362(M-1)。Sodium metal (9.2g, 0.4mol) was dissolved in ethanol (150ml), and after the sodium was completely dissolved, it was refluxed for 10 minutes. After the reaction solution was cooled to 50°C-60°C, ethyl cyanoacetate (47.0ml, 0.44 mol), after 10 minutes, a large amount of white powder was formed in the reaction solution, and then refluxed for 30 minutes, and then cooled to -8°C in an ice-salt bath. Add dropwise anhydrous THF solution (150ml) of 3-acetamido-4-ethoxy-6-nitrobenzoyl chloride to the reaction liquid, and finish adding after 1h, keeping the reaction temperature below 0°C, and the reaction is complete after the dropwise addition Finish. Add ice water (100ml) dropwise to the reaction solution, keep the temperature of the reaction solution below 10°C, then add a solution of concentrated sulfuric acid (10ml, 0.15mol) in ice water (1000ml) to the reaction solution, adjust the pH value of the reaction solution to 1 -2, a large amount of solids were precipitated, stirred for 1 hour, suction filtered, washed, and dried to obtain 3-(5-acetamido-4-ethoxy-2-nitrophenyl)-2-cyano- 3-Carbonyl-propionic acid ethyl ester (compound V, R 1 = acetyl, R 2 = ethyl, R 4 = ethyl, X = cyano, Z = -NH-) 68.0 g, yield 93.5%. 1 HNMR (300MHz, DMSO) δ0.96(t, 3H), 1.43(t, 3H), 2.20(s, 3H), 3.86(q, 2H), 4.28(q, 2H), 7.79(s, 1H) , 8.14(s, 1H), 9.51(s, 1H). ESI-Ms (m/z) 362 (M-1).
实施例十六3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 16 3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano base, Z=-NH-) synthesis
将化合物V(R1=乙酰基,R2=乙基,R4=乙基,X=氰基,Z=-NH-)(36.3g,0.1mol)溶于96% DMSO/水(160ml),于110℃反应30min。反应液冷却后用水(800ml)稀释,析出黄色粉末,用1N硫酸调溶液pH为1-2,抽滤,水洗,干燥,得到淡黄色固体的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)25.8g,收率88.6%。1HNMR(300MHz,CDCl3)δ1.56(t,3H),2.28(s,3H),3.85(s,2H),4.28(q,2H),7.64(s,1H),8.02(s,1H),8.58(s,1H)。Compound V (R 1 = acetyl, R 2 = ethyl, R 4 = ethyl, X = cyano, Z = -NH-) (36.3 g, 0.1 mol) was dissolved in 96% DMSO/water (160 ml) , reacted at 110°C for 30min. After the reaction solution was cooled, it was diluted with water (800ml), and a yellow powder was precipitated. The pH of the solution was adjusted to 1-2 with 1N sulfuric acid, filtered with suction, washed with water, and dried to obtain 3'-acetamido-4'-ethoxy -6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 25.8 g, yield 88.6%. 1 HNMR (300MHz, CDCl 3 ) δ1.56(t, 3H), 2.28(s, 3H), 3.85(s, 2H), 4.28(q, 2H), 7.64(s, 1H), 8.02(s, 1H ), 8.58(s, 1H).
实施例十七 3’-苯甲酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=苯甲酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 17 3'-benzamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = benzoyl, R 2 = ethyl, X = cyano group, Z = -NH-) synthesis
以3-氨基-4-羟基苯乙酮为原料,按照实施例一的步骤3、4以及实施例二至四的操作,经苯甲酰化、乙基化、硝化、溴代、氰基化制备标题化合物,得黄色粉末的标题化合物3’-苯甲酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=苯甲酰基,R2=乙基,X=氰基,Z=-NH-),总收率56%。ESI-MS(m/z)352(M-1)。Using 3-amino-4-hydroxyacetophenone as a raw material, according to the steps 3 and 4 of Example 1 and the operations of Examples 2 to 4, through benzoylation, ethylation, nitration, bromination, and cyanation The title compound was prepared to give the title compound 3'-benzamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 =benzoyl, R 2 = ethyl, X = cyano, Z = -NH-), the total yield was 56%. ESI-MS (m/z) 352 (M-1).
实施例十八 3’-苄胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=苄基,R2=乙基,X=氰基,Z=-NH-)的合成Example 18 3'-benzylamino-4'-ethoxy-6'-nitro-2-cyanoacetophenone (Compound I, R 1 = benzyl, R 2 = ethyl, X = cyano base, Z=-NH-) synthesis
以3-苄胺基-4-乙氧基苯乙酮为原料,按照实施例二至四的操作,同法制备标题化合物,得黄色粉末的标题化合物3’-苄胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=苄基,R2=乙基,X=氰基,Z=-NH-)。ESI-MS(m/z)338(M-1)。Using 3-benzylamino-4-ethoxyacetophenone as raw material, according to the operation of Examples 2 to 4, the title compound was prepared in the same way to obtain the title compound 3'-benzylamino-4'-B as a yellow powder Oxy-6'-nitro-2-cyanoacetophenone (Compound I, R 1 =benzyl, R 2 =ethyl, X=cyano, Z=-NH-). ESI-MS (m/z) 338 (M-1).
实施例十九3’-乙酰胺基-4’-乙氧基-6’-氨基-2-氰基苯乙酮(化合物VIII,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 19 3'-acetamido-4'-ethoxy-6'-amino-2-cyanoacetophenone (compound VIII, R 1 = acetyl, R 2 = ethyl, X = cyano , Z=-NH-) synthesis
化合物I(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(29.1g,0.1mol)、铁粉(28g,0.5mol)与400ml四氢呋喃、50ml乙醇、20ml水混合,加稀盐酸调pH=4-5,回流2h,反应结束。过滤,蒸干溶剂得褐色固体,用四氢呋喃/乙酸乙酯(1∶1,200ml)打浆得灰黄色固体的化合物VIII(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)21.5g,收率81%。1HNMR(300MHz,DMSO)δ1.36(t,3H),1.99(s,3H),3.27(s,2H),4.00(q,2H),6.33(s,1H),7.28(s,1H),7.76(s,1H),8.88(s,1H)。EI-MS(m/z)261(M+)。Compound I (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (29.1g, 0.1mol), iron powder (28g, 0.5mol) and 400ml tetrahydrofuran, 50ml ethanol, 20ml Mix with water, add dilute hydrochloric acid to adjust pH=4-5, reflux for 2h, and the reaction is over. Filter and evaporate the solvent to obtain a brown solid, which was slurried with tetrahydrofuran/ethyl acetate (1:1, 200ml) to obtain compound VIII (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 21.5g, yield 81%. 1 HNMR (300MHz, DMSO) δ1.36(t, 3H), 1.99(s, 3H), 3.27(s, 2H), 4.00(q, 2H), 6.33(s, 1H), 7.28(s, 1H) , 7.76(s, 1H), 8.88(s, 1H). EI-MS (m/z) 261 (M + ).
实施例二十 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 20 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = - Synthesis of NH-)
室温,化合物VIII(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(26.1g,0.1mol)溶于乙二醇二甲醚(250mL),加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(16.0ml,0.12mol),反应4h,反应液中析出灰黄色粉末,抽滤,洗涤,干燥得灰黄色固体6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)22.5g,收率83.0%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。At room temperature, compound VIII (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (26.1 g, 0.1 mol) was dissolved in ethylene glycol dimethyl ether (250 mL), N was added, N-diformamide dimethyl acetal (DMF-DMA) (16.0ml, 0.12mol), reacted for 4h, gray-yellow powder precipitated in the reaction solution, suction filtered, washed, dried to give gray-yellow solid 6-acetamido-7 - Ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 22.5 g, yield 83.0%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).
实施例二十一 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 21 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis
冰浴下,化合物VIII·HCl(即VIII的盐酸盐,R1=乙酰基,R2=乙基,X =氰基,Z=-NH-)(29.7g,0.1mol)与乙二醇二甲醚混合,冰浴,滴加N,N-二甲酰胺二甲缩醛(DMF-DMA)(13.3ml,0.1mol),反应4h,反应结束。将反应液浓缩至一半体积,滤液倒入碎冰(100g)中,放置1h,析出土黄色固体,抽滤,水洗,干燥得土黄色固体6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)23.5g,收率80%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Under ice bath, compound VIII·HCl (the hydrochloride salt of VIII, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (29.7 g, 0.1 mol) and ethylene glycol Dimethyl ether was mixed, ice bathed, N,N-dimethylamide dimethyl acetal (DMF-DMA) (13.3ml, 0.1mol) was added dropwise, reacted for 4h, and the reaction was completed. Concentrate the reaction solution to half its volume, pour the filtrate into crushed ice (100g), and let it stand for 1h. A khaki solid precipitates, which is filtered with suction, washed with water, and dried to obtain a khaki solid 6-acetamido-7-ethoxy-3- Cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 23.5 g, yield 80%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).
实施例二十二 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 22 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis
化合物VIII(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(26.1g,0.1mol)悬浮于乙二醇二甲醚(250ml),加入原甲酸三乙酯(20.0ml,0.12mol),回流反应3h,反应结束。反应液中析出土黄色粉末,抽滤,洗涤,干燥得土黄色固体的6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)20.5g,收率76%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Compound VIII (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (26.1 g, 0.1 mol) was suspended in ethylene glycol dimethyl ether (250 ml), and triethyl orthoformate was added Ester (20.0ml, 0.12mol) was refluxed for 3h, and the reaction was completed. A khaki powder was precipitated in the reaction solution, filtered by suction, washed, and dried to obtain 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 =acetyl , R 2 = ethyl, X = cyano, Z = -NH-) 20.5 g, yield 76%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).
实施例二十三2-(5-乙酰氨基-4-乙氧基-2-硝基苯甲酰基)丙二酸二乙酯(化合物V,R1=乙基,R2=乙基,X=乙氧基羰基,R4=乙基,Z=-NH-)的合成Example 23 Diethyl 2-(5-acetylamino-4-ethoxy-2-nitrobenzoyl)malonate (compound V, R 1 = ethyl, R 2 = ethyl, X = ethoxycarbonyl, R 4 = ethyl, Z = -NH-) synthesis
常温下,将3-乙酰胺基-4-乙氧基-6-硝基苯甲酸(5.3g,0.02mol)悬浮于二氯甲烷(60ml)中,加入氯化亚砜(7.2ml,0.1mol),回流反应,1h后反应结束,反应液澄清。蒸干溶剂得褐色固体,加入无水THF溶液(30ml),蒸干,得3-乙酰胺基-4-乙氧基-6-硝基苯甲酰氯,可直接用于下一步反应。At room temperature, 3-acetamido-4-ethoxy-6-nitrobenzoic acid (5.3g, 0.02mol) was suspended in dichloromethane (60ml), and thionyl chloride (7.2ml, 0.1mol ), reflux reaction, the reaction ended after 1h, and the reaction solution was clarified. The solvent was evaporated to dryness to obtain a brown solid, which was added with anhydrous THF solution (30ml) and evaporated to dryness to obtain 3-acetamido-4-ethoxy-6-nitrobenzoyl chloride, which could be directly used in the next reaction.
常温下,将金属钠(1.0g,0.043mol)溶于乙醇(30ml),待钠全溶后再回流反应10min,待反应液冷却至50℃-60℃,滴加丙二酸二乙酯(7.0ml,0.046mol),3min加完,再回流反应30min,溶液澄清,而后冷却至-10℃。向反应液中滴加3-乙酰胺基-4-乙氧基-6-硝基苯甲酰氯的无水THF溶液(30ml),20min加完,保持反应温度0℃以下,滴加完毕反应即结束。向反应液中滴加冰水(20ml),保持反应液温度在0℃以下,再用稀硫酸调反应液pH值为1-2,搅拌放置,析出固体,抽滤,洗涤,干燥得黄褐色固体的2-(5-乙酰氨基-4-乙氧基-2-硝基苯甲酰基)丙二酸二乙酯(化合物V,R1=乙基,R2=乙基,X=乙氧基羰基,R4=乙基,Z=-NH-)6.4g,收率78.0%。1H-NMR(300MHz,CDCl3)δ0.98(t,3H),1.36(t,3H),1.53(t,3H),2.23(s,3H),3.94(q,2H),4.24(q,2H),4.37(q,2H),7.67(s,1H),7.91(s,1H),8.53(s,1H),14.1(s,1H)。EI-MS(m/z)410(M+)。At room temperature, dissolve metal sodium (1.0g, 0.043mol) in ethanol (30ml), and then reflux for 10 minutes after the sodium is completely dissolved. After the reaction solution is cooled to 50°C-60°C, diethyl malonate ( 7.0ml, 0.046mol), the addition was completed in 3 minutes, and the reaction was refluxed for 30 minutes. The solution was clear, and then cooled to -10°C. Add dropwise anhydrous THF solution (30ml) of 3-acetamido-4-ethoxy-6-nitrobenzoyl chloride to the reaction solution, and finish adding in 20 minutes, keep the reaction temperature below 0°C, and the reaction is complete after the dropwise addition Finish. Add ice water (20ml) dropwise to the reaction solution, keep the temperature of the reaction solution below 0°C, then use dilute sulfuric acid to adjust the pH of the reaction solution to 1-2, stir and let it stand, precipitate solid, suction filter, wash, and dry to obtain yellowish brown Solid diethyl 2-(5-acetylamino-4-ethoxy-2-nitrobenzoyl)malonate (compound V, R 1 = ethyl, R 2 = ethyl, X = ethoxy Carbonyl, R 4 = ethyl, Z = -NH-) 6.4 g, yield 78.0%. 1 H-NMR (300MHz, CDCl 3 ) δ0.98(t, 3H), 1.36(t, 3H), 1.53(t, 3H), 2.23(s, 3H), 3.94(q, 2H), 4.24(q , 2H), 4.37(q, 2H), 7.67(s, 1H), 7.91(s, 1H), 8.53(s, 1H), 14.1(s, 1H). EI-MS (m/z) 410 (M + ).
实施例二十四 3’-乙酰胺基-4’-乙氧基-6’-硝基-2-乙氧基羰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)的合成Example 24 3'-acetamido-4'-ethoxy-6'-nitro-2-ethoxycarbonylacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, Synthesis of X=ethoxycarbonyl, Z=-NH-)
将化合物V(R1=乙基,R2=乙基,X=乙氧基羰基,R4=乙基,Z=-NH-)(3.1g,0.0076mol)溶于90% DMSO/水(20ml),于110℃反应30min。反应液冷却后用水(150ml)稀释,析出黄色粉末,用稀硫酸调反应液pH值为2-3,搅拌放置,析出固体,抽滤,洗涤,干燥得淡黄色固体的化合物I(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)2.3g,收率91.0%。1H-NMR(300MHz,CDCl3)δ1.25(t,3H),1.53(t,3H),2.25(s,3H),3.83(s,2H),4.17(q,2H),4.24(q,2H),7.59(s,1H),7.95(s,1H),8.59(s,1H)。EI-MS(m/z)338(M+)。Compound V (R 1 = ethyl, R 2 = ethyl, X = ethoxycarbonyl, R 4 = ethyl, Z = -NH-) (3.1 g, 0.0076 mol) was dissolved in 90% DMSO/water ( 20ml), react at 110°C for 30min. After the reaction solution was cooled, it was diluted with water (150ml), and a yellow powder was precipitated. The pH value of the reaction solution was adjusted to 2-3 with dilute sulfuric acid, stirred and placed, and a solid was precipitated, filtered by suction, washed, and dried to obtain compound I (R1=acetyl base, R2=ethyl, X=ethoxycarbonyl, Z=-NH-) 2.3 g, yield 91.0%. 1 H-NMR (300MHz, CDCl 3 ) δ1.25(t, 3H), 1.53(t, 3H), 2.25(s, 3H), 3.83(s, 2H), 4.17(q, 2H), 4.24(q , 2H), 7.59(s, 1H), 7.95(s, 1H), 8.59(s, 1H). EI-MS (m/z) 338 (M + ).
实施例二十五 N-(5-(2-乙氧基羰基-3-(二甲基胺基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺(化合物VI,R1=乙酰基,R2=乙基,X=乙氧基羰基,Y=-N(CH3)2,Z=-NH-)的合成Example 25 N-(5-(2-ethoxycarbonyl-3-(dimethylamino)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide (compound VI, Synthesis of R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Y = -N(CH 3 ) 2 , Z = -NH-)
将化合物I(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)(0.8g,0.00236mol)溶于乙二醇二甲醚(20ml),加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(0.93ml,0.007mol),回流反应6-8h,反应结束。蒸干溶剂得淡黄色固体化合物VI(R1=乙酰基,R2=乙基,X=乙氧基羰基,Y=-N(CH3)2,Z=-NH-)0.95g,可直接用于下一步反应。1H-NMR(300MHz,CDCl3)δ0.91(t,3H),1.45(t,3H),2.17(s,3H),3.04(s,3H),3.32(s,3H),3.87(q,2H),4.16(q,2H),7.53(s,1H),7.92(s,1H),7.98(s,1H),9.39(s,1H)。EI-MS(m/z)393(M+)。Compound I (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) (0.8 g, 0.00236 mol) was dissolved in ethylene glycol dimethyl ether (20 ml), and N , N-diformamide dimethyl acetal (DMF-DMA) (0.93ml, 0.007mol), reflux reaction for 6-8h, the reaction ended. The solvent was evaporated to dryness to obtain 0.95 g of light yellow solid compound VI (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Y = -N(CH 3 ) 2 , Z = -NH-), which can be directly for the next reaction. 1 H-NMR (300MHz, CDCl 3 ) δ0.91(t, 3H), 1.45(t, 3H), 2.17(s, 3H), 3.04(s, 3H), 3.32(s, 3H), 3.87(q , 2H), 4.16 (q, 2H), 7.53 (s, 1H), 7.92 (s, 1H), 7.98 (s, 1H), 9.39 (s, 1H). EI-MS (m/z) 393 (M + ).
实施例二十六 化合物VIII(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)的合成Example 26 Synthesis of Compound VIII (R 1 = Acetyl, R 2 = Ethyl, X = Ethoxycarbonyl, Z = -NH-)
将化合物I(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)(0.8g,0.00236mol)溶于THF(20ml),加入Raney Ni(0.2g),室温氢化反应12h,反应结束。过滤,蒸干滤液得黄褐色固体的化合物VIII(R1=乙酰基,R2=乙基,X=乙氧羰基,Z=-NH-)0.67g,收率91.5%。1H-NMR(300MHz,CDCl3)δ1.22(t,3H),1.48(t,3H),2.20(s,3H),3.95(s,2H),4.18(q,2H),4.24(q,2H),6.05(s,1H),6.31(s,1H),7.45(s,1H),8.63(s,1H)。ESI-MS(m/z)331(M+23)。Compound I (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) (0.8 g, 0.00236 mol) was dissolved in THF (20 ml), and Raney Ni (0.2 g) was added , hydrogenation reaction at room temperature for 12h, the reaction ended. After filtration, the filtrate was evaporated to dryness to obtain 0.67 g of compound VIII (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) as a tan solid, with a yield of 91.5%. 1 H-NMR (300MHz, CDCl 3 ) δ1.22(t, 3H), 1.48(t, 3H), 2.20(s, 3H), 3.95(s, 2H), 4.18(q, 2H), 4.24(q , 2H), 6.05 (s, 1H), 6.31 (s, 1H), 7.45 (s, 1H), 8.63 (s, 1H). ESI-MS (m/z) 331 (M+23).
实施例二十七 6-乙酰胺基-7-乙氧基-3-氨基羰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)的合成Example 27 6-acetamido-7-ethoxy-3-aminocarbonyl-4-hydroxyquinoline (Compound A, R 1 =acetyl, R2 =ethyl, X =ethoxycarbonyl, Z =-NH-) Synthesis
将化合物VI(R1=乙酰基,R2=乙基,X=乙氧基羰基,Y=-N(CH3)2,Z=-NH-)(0.4g,1mmol)溶于DMF(3mL),加入RaneyNi 0.1g,常压氢化反应4h,反应结束。过滤,滤液浓缩至一半体积,再用水(4mL)稀释,析出白色固体,抽滤,水洗,干燥,得淡黄色粉末的6-乙酰胺基-7-乙氧基-3-氨基羰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)0.20g,收率62%。1H-NMR(300MHz,DMSO)δ1.26(t,3H),1.47(t,3H),2.18(s,3H),4.20(q,4H),7.07(s,1H),7.36(s,1H),8.68(s,1H),9.13(s,1H),12.04(s,1H)。EI-MS(m/z)318(M+)。Compound VI (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Y = -N(CH 3 ) 2 , Z = -NH-) (0.4 g, 1 mmol) was dissolved in DMF (3 mL ), adding RaneyNi 0.1g, atmospheric pressure hydrogenation reaction 4h, the reaction ended. Filtration, the filtrate was concentrated to half volume, and then diluted with water (4mL), a white solid was precipitated, filtered with suction, washed with water, and dried to obtain 6-acetamido-7-ethoxy-3-aminocarbonyl-4- Hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) 0.20 g, yield 62%. 1 H-NMR (300MHz, DMSO) δ1.26(t, 3H), 1.47(t, 3H), 2.18(s, 3H), 4.20(q, 4H), 7.07(s, 1H), 7.36(s, 1H), 8.68(s, 1H), 9.13(s, 1H), 12.04(s, 1H). EI-MS (m/z) 318 (M + ).
实施例二十八 6-乙酰胺基-7-乙氧基-3-氨基羰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)的合成Example 28 6-acetamido-7-ethoxy-3-aminocarbonyl-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Synthesis of Z=-NH-)
常温,化合物VIII(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)(0.31g,1mmol)悬浮于乙二醇二甲醚(4mL),加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(0.16mL,1.2mol),反应2h,反应液中析出土黄色粉末,抽滤,洗涤,干燥得土黄色固体6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)0.22g,收率69%。At room temperature, compound VIII (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) (0.31 g, 1 mmol) was suspended in ethylene glycol dimethyl ether (4 mL), and N , N-diformamide dimethyl acetal (DMF-DMA) (0.16mL, 1.2mol), reacted for 2h, a khaki powder was precipitated in the reaction solution, suction filtered, washed, and dried to obtain a khaki solid 6-acetamido- 7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) 0.22 g, yield 69%.
实施例二十九 6-乙酰胺基-7-乙氧基-3-氰基-4-氯喹啉(化合物A’,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 29 6-acetamido-7-ethoxy-3-cyano-4-chloroquinoline (compound A', R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis
将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=N(CH3)2,Z=-NH-)(15.5g,0.045mol)溶于DMF(130ml),加入Raney Ni 6g,常压氢化反应5~6h,TLC检测反应结束。过滤,滤液浓缩至干,所得产物再用二乙二醇二甲醚(120ml)溶解,加入三氯氧磷(9.3ml,0.099mol),于80℃(外温)下反应。4hr至4.5hr反应完毕,将反应液缓慢倒入2体积冰水中并搅拌1h,析出黄色粉末,抽滤,水洗,再用少量乙二醇二甲醚洗涤,40℃下干燥,得黄色粉末的化合物A’(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)9.12g,收率70.6%。1HNMR(300MHz,DMSO)δ1.49(t,3H),2.25(s,3H),4.38(q,2H),7.58(s,1H),8.98(s,1H),9.09(s,1H),9.51(s,1H)。ESI-Ms(m/z)289(M-1)。Compound VI (R 1 = acetyl, R 2 = ethyl, X = cyano, Y = N(CH 3 ) 2 , Z = -NH-) (15.5 g, 0.045 mol) was dissolved in DMF (130 ml), Add 6g of Raney Ni, hydrogenation reaction at atmospheric pressure for 5-6h, TLC detection of the end of the reaction. After filtration, the filtrate was concentrated to dryness, and the obtained product was dissolved in diethylene glycol dimethyl ether (120ml), and phosphorus oxychloride (9.3ml, 0.099mol) was added to react at 80°C (external temperature). After 4hr to 4.5hr, the reaction is completed. Slowly pour the reaction solution into 2 volumes of ice water and stir for 1 hour. A yellow powder precipitates. Suction filtration, washing with water, washing with a small amount of ethylene glycol dimethyl ether, and drying at 40°C gives a yellow powder. Compound A' (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) 9.12 g, yield 70.6%. 1 HNMR (300MHz, DMSO) δ1.49(t, 3H), 2.25(s, 3H), 4.38(q, 2H), 7.58(s, 1H), 8.98(s, 1H), 9.09(s, 1H) , 9.51 (s, 1H). ESI-Ms (m/z) 289 (M-1).
实施例三十 6-乙酰胺基-7-乙氧基-3-氰基-4-氯喹啉(化合物A’,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 30 6-acetamido-7-ethoxy-3-cyano-4-chloroquinoline (compound A', R 1 = acetyl, R 2 = ethyl, X = cyano, Z = - Synthesis of NH-)
化合物VIII(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(11.75g,0.045mol)悬浮于乙二醇二甲醚(250ml),加入原甲酸三乙酯(20.0ml,0.12mol),回流反应3h,反应结束。冷至室温,再加入三氯氧磷(11ml),于80℃(外温)下反应。4hr至4.5hr反应完毕,将反应液缓慢倒入2体积冰水中并搅拌1h,析出黄色粉末,抽滤,水洗,再用少量乙二醇二甲醚洗涤,40℃下干燥,得黄色粉末的化合物A’(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)8.9g,收率68.5%。1HNMR(300MHz,DMSO)δ1.49(t,3H),2.25(s,3H),4.38(q,2H),7.58(s,1H),8.98(s,1H),9.09(s,1H),9.51(s,1H)。ESI-Ms(m/z)289(M-1)。Compound VIII (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (11.75 g, 0.045 mol) was suspended in ethylene glycol dimethyl ether (250 ml), and triethyl orthoformate was added Ester (20.0ml, 0.12mol) was refluxed for 3h, and the reaction was completed. After cooling to room temperature, phosphorus oxychloride (11 ml) was added and reacted at 80°C (external temperature). After 4hr to 4.5hr, the reaction is completed. Slowly pour the reaction solution into 2 volumes of ice water and stir for 1 hour. A yellow powder precipitates. Suction filtration, washing with water, washing with a small amount of ethylene glycol dimethyl ether, and drying at 40°C gives a yellow powder. Compound A' (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) 8.9 g, yield 68.5%. 1 HNMR (300MHz, DMSO) δ1.49(t, 3H), 2.25(s, 3H), 4.38(q, 2H), 7.58(s, 1H), 8.98(s, 1H), 9.09(s, 1H) , 9.51 (s, 1H). ESI-Ms (m/z) 289 (M-1).
实施例三十一 3’-乙酰胺基-4’-乙氧基-6’-氨基-2-氰基苯乙酮(化合物X,R1=乙酰基,R2=乙基,X=氰基,R8=叔丁氧羰基,Z=-NH-)的合成Example 31 3'-acetamido-4'-ethoxy-6'-amino-2-cyanoacetophenone (compound X, R 1 = acetyl, R 2 = ethyl, X = cyano group, R 8 = tert-butoxycarbonyl, Z = -NH-) synthesis
将实施例十九的标题化合物(1g,0.0038mol)溶于12mL吡啶,室温下加入(BOC)2O(0.83mL,0.0046mol,)。室温反应12hr,反应液加20mL水,用二氯甲烷萃取3次(10mL/次),合并有机相,有机相用无水硫酸钠干燥,后蒸干溶剂,得淡黄色固体1.10g,收率80%。The title compound of Example 19 (1 g, 0.0038 mol) was dissolved in 12 mL of pyridine, and (BOC) 2 O (0.83 mL, 0.0046 mol,) was added at room temperature. React at room temperature for 12 hours, add 20 mL of water to the reaction solution, extract 3 times with dichloromethane (10 mL/time), combine the organic phases, dry the organic phases with anhydrous sodium sulfate, and evaporate the solvent to obtain 1.10 g of a light yellow solid. 80%.
实施例三十二 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 32 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis
冰浴下,化合物X(R1=乙酰基,R2=乙基,X=氰基,R8=叔丁氧羰基,Z=-NH-)(0.1mol)溶于乙二醇二甲醚(250mL),加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(16.0ml,0.12mol),反应5h,加入对甲苯磺酸(0.1mol),反应液中析出土黄色粉末,抽滤,洗涤,干燥得土黄色固体6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)22.5g,收率83.0%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Compound X (R 1 = acetyl, R 2 = ethyl, X = cyano, R 8 = tert-butoxycarbonyl, Z = -NH-) (0.1 mol) was dissolved in ethylene glycol dimethyl ether under ice bath (250mL), add N,N-diformamide dimethyl acetal (DMF-DMA) (16.0ml, 0.12mol), react for 5h, add p-toluenesulfonic acid (0.1mol), the reaction solution precipitates khaki powder, Suction filtration, washing, and drying to obtain khaki solid 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (Compound A, R 1 =acetyl, R 2 =ethyl, X = Cyano, Z=-NH-) 22.5g, yield 83.0%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).
实施例三十三 6-苯甲酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=苯甲酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 33 6-benzamido-7-ethoxy-3-cyano-4-hydroxyquinoline (Compound A, R 1 =benzoyl, R 2 =ethyl, X = cyano, Synthesis of Z=-NH-)
以实施例十七的标题化合物为原料,按照实施例19~20的操作,同法制备实施例三十三的标题化合物,总收率71%。ESI-MS(m/z)332(M-1)。Using the title compound of Example 17 as a raw material, the title compound of Example 33 was prepared in the same way as in Examples 19-20, with a total yield of 71%. ESI-MS (m/z) 332 (M-1).
实施例三十四 6-苄胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=苄基,R2=乙基,X=氰基,Z=-NH-)的合成Example 34 6-benzylamino-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = benzyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis
以实施例十八的标题化合物为原料,按照实施例19~20的操作,同法制备实施例三十四的标题化合物,得黄色固体,总收率69%。ESI-MS(m/z)318(M-1)。Using the title compound of Example 18 as a raw material, the title compound of Example 34 was prepared in the same way as in Examples 19-20 to obtain a yellow solid with a total yield of 69%. ESI-MS (m/z) 318 (M-1).
实施例三十五 3-甲氧基-4-(4-甲基-1-哌嗪基)丙氧基苯乙酮(化合物B,R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,Z=-O-)的合成Example 35 3-Methoxy-4-(4-methyl-1-piperazinyl)propoxyacetophenone (compound B, R 1 =methyl, R 2 =(4-methyl- Synthesis of 1-piperazinyl)propyl, Z=-O-)
将3-甲氧基-4-(3-氯丙氧基)苯乙酮(化合物B,R1=甲基,R2=3-氯丙基,Z=-O-)(以3-甲氧基-4-羟基苯乙酮为原料按照文献制备(Journal ofMedicinal Chemistry,1989,32(1):105-118))与DMF、碳酸钾混合,60℃反应5小时,后处理同实施例一的步骤4,得实施例三十五的标题化合物。EI-MS(m/z)306(M+)。3-methoxy-4-(3-chloropropoxy)acetophenone (Compound B, R 1 =methyl, R 2 =3-chloropropyl, Z=-O-) (as 3-methyl Oxygen-4-hydroxyacetophenone was prepared according to the literature (Journal of Medicinal Chemistry, 1989, 32 (1): 105-118)), mixed with DMF and potassium carbonate, reacted at 60°C for 5 hours, and the post-treatment was the same as in Example 1. Step 4, the title compound of Example 35 was obtained. EI-MS (m/z) 306 (M + ).
实施例三十六 3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=甲基,R2=(4-甲基-1-嫩)丙基,X=氰基,Z=-O-)的合成Example 36 3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-nitro-2-cyanoacetophenone (Compound I, R 1 =methyl, R 2 =(4-methyl-1-enhen)propyl, X=cyano, Z=-O-) synthesis
参照实施例2到实施例4的合成操作,以实施例三十六的标题化合物为原料,同法制备实施例三十六的标题化合物,三步总收率69%。EI-MS(m/z)376(M+)。Referring to the synthesis operations of Examples 2 to 4, using the title compound of Example 36 as a raw material, the title compound of Example 36 was prepared in the same way, and the total yield of the three steps was 69%. EI-MS (m/z) 376 (M + ).
实施例三十七 3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-氨基-2-氰基苯乙酮(化合物VIII,R1=甲基,R2=(4-甲基-1-嫩)丙基,X=氰基,Z=-O-)的合成Example 37 3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-amino-2-cyanoacetophenone (compound VIII, R 1 = Synthesis of methyl group, R 2 =(4-methyl-1-enhenyl)propyl group, X=cyano group, Z=-O-)
化合物I(R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)采用铁粉还原,参照实施例十九的制备方法,得黄色固体的化合物VIII(R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-),收率85%。EI-MS(m/z)346(M+)。Compound I (R 1 = methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) was reduced with iron powder, referring to the preparation of Example 19 Method to obtain compound VIII (R 1 = methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) as a yellow solid with a yield of 85%. EI-MS (m/z) 346 (M + ).
实施例三十八 6-甲氧基-7-(4-甲基-1-哌嗪基)丙氧基-3-氰基-4-羟基喹啉(化合物A,R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)的合成Example 38 6-methoxy-7-(4-methyl-1-piperazinyl)propoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 =methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) synthesis
冰浴下,化合物VIII(R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)(34.6g,0.1mol)悬浮于乙二醇二甲醚(250mL),加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(16.0ml,0.12mol),反应4h,反应液中析出土黄色粉末,抽滤,洗涤,干燥得土黄色固体6-甲氧基-7-(4-甲基-1-哌嗪基)丙氧基-3-氰基-4-羟基喹啉(化合物A,R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)29.5g,收率82.8%。ESI-MS(m/z)357(M+1)。Compound VIII (R 1 = methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) (34.6 g, 0.1 mol) was suspended under ice bath Add N,N-diformamide dimethyl acetal (DMF-DMA) (16.0ml, 0.12mol) to ethylene glycol dimethyl ether (250mL) and react for 4h. A khaki powder is precipitated in the reaction solution, which is suction filtered. Wash and dry to obtain khaki solid 6-methoxy-7-(4-methyl-1-piperazinyl)propoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 =methyl , R 2 =(4-methyl-1-piperazinyl)propyl, X=cyano, Z=-O-) 29.5 g, yield 82.8%. ESI-MS (m/z) 357 (M+1).
实施例三十九 6-甲氧基-7-(4-甲基-1-哌嗪基)丙氧基-3-氰基-4-氯喹啉(化合物A’,R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)的合成Example 39 6-methoxy-7-(4-methyl-1-piperazinyl)propoxy-3-cyano-4-chloroquinoline (compound A', R 1 =methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) synthesis
化合物VIII(R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)(15.6g,0.045mol)悬浮于乙二醇二甲醚(250ml),加入原甲酸三乙酯(20.0ml,0.12mol),回流反应3h,反应结束。冷至室温,再加入三氯氧磷(11ml),于80℃(外温)下反应。4hr至4.5hr反应完毕,将反应液缓慢倒入2体积冰水中并搅拌1h,析出黄色粉末,抽滤,水洗,再用少量乙二醇二甲醚洗涤,40℃下干燥,得黄色粉末的化合物A’(R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)11.5g,收率68%。EI-MS(m/z)376(M+)。Compound VIII (R 1 = methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) (15.6 g, 0.045 mol) suspended in ethylene glycol Dimethyl ether (250ml), triethyl orthoformate (20.0ml, 0.12mol) was added, refluxed for 3h, and the reaction was completed. After cooling to room temperature, phosphorus oxychloride (11 ml) was added and reacted at 80°C (external temperature). After 4hr to 4.5hr, the reaction is completed. Slowly pour the reaction solution into 2 volumes of ice water and stir for 1 hour. A yellow powder is precipitated, filtered with suction, washed with water, washed with a small amount of ethylene glycol dimethyl ether, and dried at 40°C to obtain a yellow powder. Compound A' (R 1 =methyl, R 2 =(4-methyl-1-piperazinyl)propyl, X=cyano, Z=-O-) 11.5g, yield 68%. EI-MS (m/z) 376 (M + ).
实施例四十 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 40 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = - Synthesis of NH-)
将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)(15g,0.0433mol)悬浮于乙醇(200mL)、水(200mL)和冰乙酸(4mL,0.065mol),加入锌粉(22g,0.35mol),100℃回流反应约12h,TLC检测反应完全后,略冷却,直接向反应液中加NaOH(0.13mol),反应液混浊。接着进行抽滤,而后进行如下步骤:Compound VI (R 1 = acetyl, R 2 = ethyl, X = cyano, Y = -N(CH 3 ) 2 , Z = -NH-) (15 g, 0.0433 mol) was suspended in ethanol (200 mL), Add water (200mL) and glacial acetic acid (4mL, 0.065mol), add zinc powder (22g, 0.35mol), reflux at 100°C for about 12h, after TLC detects that the reaction is complete, cool slightly, and directly add NaOH (0.13mol ), the reaction solution was turbid. Carry out suction filtration then, then carry out following steps:
将上述滤液在50-60℃调pH至3以下,析出产物。过滤,水洗,干燥,得标题化合物(酮式结构)10.1g,收率86%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(d,1H),8.70(s,1H),9.21(s,1H),12.58(d,1H)。ESI-Ms(m/z)270(M-1)。Adjust the pH of the above filtrate to below 3 at 50-60°C to precipitate the product. Filter, wash with water, and dry to obtain 10.1 g of the title compound (ketone structure), with a yield of 86%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(d, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(d, 1H). ESI-Ms (m/z) 270 (M-1).
或者,将上述滤液在50-60℃调pH至5-6,析出产物。过滤,水洗,干燥,得标题化合物(酚式结构)10.0g,收率85%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.19(q,2H),7.15(s,1H),8.56(s,1H),8.69(s,1H),9.19(s,1H)。ESI-Ms(m/z)270(M-1)。Alternatively, adjust the pH of the above filtrate to 5-6 at 50-60° C. to precipitate the product. Filter, wash with water, and dry to obtain 10.0 g of the title compound (phenolic structure), with a yield of 85%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.19(q, 2H), 7.15(s, 1H), 8.56(s, 1H), 8.69(s, 1H) , 9.19(s, 1H). ESI-Ms (m/z) 270 (M-1).
酮式结构 酚式结构Keto structure Phenolic structure
实施例四十一 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 41 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis
将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)(15g,0.0433mol)悬浮于乙醇(300mL),再加入Fe粉(11g,0.18mol)、CaCl2(10g,0.0866mol),回流15h反应结束。略冷却,直接向反应液中加NaOH(0.13mol),反应液混浊,抽滤,上述滤液在50-60℃调pH至3以下,析出产物。过滤,水洗,干燥,得标题化合物6.7g,收率57%。Compound VI (R 1 =acetyl, R 2 =ethyl, X=cyano, Y=-N(CH 3 ) 2 , Z=-NH-) (15 g, 0.0433 mol) was suspended in ethanol (300 mL), Add Fe powder (11 g, 0.18 mol) and CaCl 2 (10 g, 0.0866 mol) and reflux for 15 h to complete the reaction. After slightly cooling, NaOH (0.13 mol) was directly added to the reaction solution, the reaction solution was turbid, filtered with suction, the pH of the above filtrate was adjusted to below 3 at 50-60°C, and the product was precipitated. Filter, wash with water, and dry to obtain 6.7 g of the title compound, with a yield of 57%.
实施例四十二 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 42 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) synthesis
将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)(15g,0.0433mol)悬浮于冰乙酸(300mL),再加入1g5%钯碳、室温常压通氢气反应,15h反应结束。反应液中逐渐析出固体。抽滤,水洗,干燥,得标题化合物7.1g,收率61%。Compound VI (R 1 =acetyl, R 2 =ethyl, X=cyano, Y=-N(CH 3 ) 2 , Z=-NH-) (15 g, 0.0433 mol) was suspended in glacial acetic acid (300 mL) , and then add 1g of 5% palladium carbon, and react with hydrogen gas at room temperature and pressure, and the reaction is completed in 15 hours. Solids gradually precipitated out of the reaction solution. Suction filtration, washing with water, and drying gave 7.1 g of the title compound with a yield of 61%.
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200980129186.8A CN102105433B (en) | 2008-06-13 | 2009-06-12 | 6-nitroacetophenone compound, its preparation method and use |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA200810038964XA CN101602687A (en) | 2008-06-13 | 2008-06-13 | 6-nitroacetophenone compound, its preparation method and use |
CN200810038964.X | 2008-06-13 | ||
CN200980129186.8A CN102105433B (en) | 2008-06-13 | 2009-06-12 | 6-nitroacetophenone compound, its preparation method and use |
PCT/CN2009/000653 WO2009149622A1 (en) | 2008-06-13 | 2009-06-12 | 6-nitro acetophenone compounds, preparation methods and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102105433A CN102105433A (en) | 2011-06-22 |
CN102105433B true CN102105433B (en) | 2014-09-10 |
Family
ID=41416356
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA200810038964XA Pending CN101602687A (en) | 2008-06-13 | 2008-06-13 | 6-nitroacetophenone compound, its preparation method and use |
CN200980129186.8A Expired - Fee Related CN102105433B (en) | 2008-06-13 | 2009-06-12 | 6-nitroacetophenone compound, its preparation method and use |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA200810038964XA Pending CN101602687A (en) | 2008-06-13 | 2008-06-13 | 6-nitroacetophenone compound, its preparation method and use |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN101602687A (en) |
WO (1) | WO2009149622A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105693524A (en) * | 2014-11-28 | 2016-06-22 | 浙江省化工研究院有限公司 | A preparing method of nitro compounds |
KR102622104B1 (en) * | 2015-06-30 | 2024-01-09 | (주)아모레퍼시픽 | Preparation method of benzoic acid amide compounds |
CN105461565B (en) * | 2015-11-17 | 2017-12-29 | 阜宁县安勤化学有限公司 | A kind of method for producing nitro-acetophenone |
CN109553533A (en) * | 2017-09-27 | 2019-04-02 | 江苏瑞科医药科技有限公司 | Flurbiprofen intermediate and preparation method thereof |
CN115819243B (en) * | 2022-10-19 | 2024-03-29 | 浙江理工大学 | Preparation method of 4-hydroxy-3-nitroacetophenone |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993007137A1 (en) * | 1991-10-11 | 1993-04-15 | Smithkline Beecham Plc | Pyridinol derivatives as medicaments |
US5276027A (en) * | 1991-10-23 | 1994-01-04 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Thiadiazinones |
CN1176101A (en) * | 1996-07-19 | 1998-03-18 | 弗·哈夫曼-拉罗切有限公司 | N -(4 -aryl -thiazol -2 -yl) -sulphonamide derivatives and their use |
CN1665787A (en) * | 2002-04-30 | 2005-09-07 | 惠氏控股公司 | Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
CN101012225A (en) * | 2007-02-01 | 2007-08-08 | 中国药科大学 | 3-Cyanoquinoline derivative, preparation method and medical use thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3478084A (en) * | 1965-12-22 | 1969-11-11 | Merck & Co Inc | Lower alkyl alpha-carboalkoxy-beta-(3,4-disubstituted anilino) acrylates |
US3485845A (en) * | 1966-05-13 | 1969-12-23 | May & Baker Ltd | Methyl and ethyl 6- and 7-substituted 4-hydroxy-quinoline-3-carboxylates useful as coccidiostats |
US3657319A (en) * | 1970-05-05 | 1972-04-18 | Smith Kline French Lab | Alpha-aminoalkyl-4-hydroxy-3-carboalkoxyaminobenzyl alcohols |
US4024281A (en) * | 1972-05-26 | 1977-05-17 | Smithkline Corporation | N,N-bis[2-(3-substituted-4-hydroxyphenyl)-ethyl or -2-hydroxyethyl]-polymethylenediamines |
US3943173A (en) * | 1972-11-22 | 1976-03-09 | Smithkline Corporation | 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols |
IL65809A (en) * | 1981-06-01 | 1986-07-31 | Merrell Toraude & Co | Aminoacid derivatives,their preparation and pharmaceutical compositions containing them |
US5134138A (en) * | 1989-07-18 | 1992-07-28 | Shionogi & Co., Ltd. | Phenacylpyridiniothiocephalosporins |
AU644008B2 (en) * | 1990-08-10 | 1993-12-02 | Sumitomo Pharmaceuticals Company, Limited | Beta-lactam compounds, and their production and use |
DE60128211T2 (en) * | 2000-03-31 | 2008-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | PHENYL-SUBSTITUTED IMIDAZOPYRIDINE |
JP2003313176A (en) * | 2002-04-24 | 2003-11-06 | Sankyo Co Ltd | Aminoazole derivative |
JP2007197369A (en) * | 2006-01-26 | 2007-08-09 | Sankyo Co Ltd | Benzothiadiazine derivative |
-
2008
- 2008-06-13 CN CNA200810038964XA patent/CN101602687A/en active Pending
-
2009
- 2009-06-12 CN CN200980129186.8A patent/CN102105433B/en not_active Expired - Fee Related
- 2009-06-12 WO PCT/CN2009/000653 patent/WO2009149622A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993007137A1 (en) * | 1991-10-11 | 1993-04-15 | Smithkline Beecham Plc | Pyridinol derivatives as medicaments |
US5276027A (en) * | 1991-10-23 | 1994-01-04 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Thiadiazinones |
CN1176101A (en) * | 1996-07-19 | 1998-03-18 | 弗·哈夫曼-拉罗切有限公司 | N -(4 -aryl -thiazol -2 -yl) -sulphonamide derivatives and their use |
CN1665787A (en) * | 2002-04-30 | 2005-09-07 | 惠氏控股公司 | Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
CN101012225A (en) * | 2007-02-01 | 2007-08-08 | 中国药科大学 | 3-Cyanoquinoline derivative, preparation method and medical use thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101602687A (en) | 2009-12-16 |
WO2009149622A1 (en) | 2009-12-17 |
CN102105433A (en) | 2011-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102105433B (en) | 6-nitroacetophenone compound, its preparation method and use | |
CN102731395B (en) | Intermediate compound of antitumor drug neratinib and its preparation method and use | |
CN101993407A (en) | Indoline compound for preparing silodosin and preparation method thereof | |
CN101402610A (en) | Synthesis method of 4-(3-chlorine-4-fluorobenzene amino)-7-methoxy-6-[3-(4-morpholinyl)-propoxy] quinoline | |
CN104030981A (en) | Preparation method and intermediate of Ivacaftor | |
CN103570633B (en) | The preparation method of Gefitinib | |
CN105418483A (en) | Preparation method of crystalline nintedanib esylate | |
CN103936631B (en) | A kind of Biphenyl carbamide compound containing oximido and its preparation method and application | |
CN107162973B (en) | Intramolecular Decarboxylation Coupling to Construct C-N Bonds to Synthesize Acridone Derivatives | |
CN110498771A (en) | A kind of method for preparing the intermediate of Elagoli | |
CN109988108A (en) | A kind of rich preparation method for Buddhist nun of card | |
CN102123981B (en) | Preparation method and intermediates of 6-substituted amino-3-cyanoquinoline compounds | |
CN104230885B (en) | The preparation method of imatinib | |
Kumar et al. | A simple and highly efficient process for synthesis of Gefitinib and its intermediate | |
CN104592222B (en) | The preparation method of antiplatelet drug AZD6482 | |
CN105837522A (en) | Preparation method of 1,5-benzodiazepine-one derivative | |
CN115197261A (en) | Synthesis method of oxadiazabenzboron derivative | |
CN114716378A (en) | A kind of synthetic method of 1,3,4-tri-substituted-5-cyanopyrazole derivatives | |
CN103172564B (en) | The preparation method of Aripiprazole | |
CN107573336A (en) | Benzheterocycle carboxamide pyridine ketone derivatives and its production and use | |
MX2008015050A (en) | Process for synthesizing piperazine-piperidine compounds. | |
CN101538252B (en) | Novel preparation method and intermediate for aripiprazole | |
JP2022546126A (en) | Benzimidazole-substituted phenyl-n-butanamide compound and method for producing same | |
CN103992308A (en) | Method for preparing sunitinib | |
CN114621109B (en) | Synthesis method of apatamide and intermediate thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140910 Termination date: 20170612 |
|
CF01 | Termination of patent right due to non-payment of annual fee |